Document:

SHARE
      EXCHANGE AGREEMENT

    

    By
      and among

    

    KAMICK
      ASSETS LIMITED,

    

    ASIAN
      BUSINESS MANAGEMENT GROUP LIMITED

     

    and

     

    AAMAXAN
      TRANSPORT GROUP, INC.

    

    dated
      as of April 14, 2008

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    SHARE
      EXCHANGE AGREEMENT

    

    This
      SHARE EXCHANGE AGREEMENT, dated as of April 14, 2008 (the “Agreement”)
      by and
      among KAMICK
      ASSETS LIMITED,
      a BVI
      Business Company incorporated in the British Virgin Islands (“KAL”),
      ASIAN
      BUSINESS MANAGEMENT GROUP LIMITED,
      a BVI
      Business Company incorporated in the British Virgin Islands (“ABM”)
      and a
      wholly-owned subsidiary of KAL,
      and
AAMAXAN
      TRANSPORT GROUP, INC.,
      a
      Delaware corporation (“ATG”).

    

    WHEREAS,
      KAL owns 100% of the issued and outstanding capital stock of ABM ("ABM
      Shares");

     

    WHEREAS,
      KAL believes it is in its best interests to exchange the ABM Shares for
      14,991,812 shares of common stock, par value $.0001 per share, of ATG (the
      “ATG
      Shares”
and
      ATG
      believes it is in its best interests to acquire the ABM Shares in exchange
      for
      ATG Shares, upon the terms and subject to the conditions set forth in this
      Agreement (the “Share
      Exchange Transaction”);
      

     

    WHEREAS,
      it the intention of the parties that: (i) ATG shall acquire 100% of the ABM
      Shares in exchange solely for the amount of ATG Shares set forth herein; (ii)
      said exchange of shares shall qualify as a tax-free reorganization under Section
      368(a)(1)(B) of the Internal Revenue Code of 1986, as amended (the “Code”);
      and
      (iii) said exchange shall qualify as a transaction in securities exempt from
      registration or qualification under the Securities Act of 1933, as amended
      and
      in effect on the date of this Agreement (the “Securities
      Act”);
      and

     

    WHEREAS,
      immediately following the consummation of the Share Exchange Transaction, ATG
      intends to enter into a private placement financing transaction with certain
      accredited investors whereby ATG will issue shares of newly-designated Series
      A
      Senior Convertible Preferred Stock, par value $.001 per share, of ATG and
      related warrants for cash (the “Financing
      Transaction”); and

     

    WHEREAS,
      the parties hereto agree that the capitalization table upon which the
      transactions contemplated by this Agreement and Financing Transaction are based
      is set forth as Schedule
      A
      hereto.

     

    NOW,
      THEREFORE, in consideration of the mutual terms, conditions and other agreements
      set forth herein, the parties hereto hereby agree as follows:

     

    ARTICLE
      I

     

    EXCHANGE
      OF SHARES FOR COMMON STOCK

     

    Section
      1.1 Agreement
      to Exchange ABM Shares for ATG Shares.
      On the
      Closing Date (as hereinafter defined) and upon the terms and subject to the
      conditions set forth in this Agreement, KAL shall sell, assign, transfer, convey
      and deliver the ABM Shares to ATG, and ATG shall accept the ABM Shares from
      KAL
      in exchange for the issuance to KAL of the ATG Shares.

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    Section
      1.2 Capitalization.
      On the
      Closing Date, immediately before the transactions to be consummated pursuant
      to
      this Agreement and the Stock Purchase Agreement, dated the date hereof by and
      among ATG, KAL and Marc Juliar, ATG shall have authorized (a) a total of
      200,000,000 shares of Common Stock, par value $.0001 per share, 243,999 shares
      of which are issued and outstanding, (b) a total of 10,000,000 shares of
      Preferred Stock, par value $.001 pe share (the “Preferred
      Stock”),
      none
      of which are issued and outstanding., but 7,500,000 shares shall have been
      designated as Series A Senior Convertible Preferred Stock (“Series
      A Stock”).
      

    

    Section
      1.3 Closing.
      The
      closing of the exchange to be made pursuant to this Agreement (the "Closing")
      shall
      take place at 5:00 p.m. E.D.T. on the day the conditions to closing set forth
      in
      Articles V and VI have been satisfied or waived, or at such other time and
      date
      as the parties hereto shall agree in writing (the "Closing
      Date"),
      at
      the offices of Guzov Ofsink, LLC, 600 Madison Avenue, 14th
      Floor,
      New York, New York 10022. At the Closing, KAL shall deliver to ATG the stock
      certificates representing 100% of the ABM Shares, duly endorsed in blank for
      transfer or accompanied by appropriate stock powers duly executed in blank.
      In
      full consideration and exchange for the ABM Shares, ATG shall issue and exchange
      with KAL the ATG Shares..

     

    ARTICLE
      II

    

    REPRESENTATIONS
      AND WARRANTIES OF ATG

    

    ATG
      hereby represents, warrants and agrees that the statements in the following
      paragraphs of this Section 2 are all true and complete as of the date hereof,
      and will, except as contemplated by this Agreement, be true and complete as
      of
      the Closing Date as if first made on such date:

    

    Section
      2.1 Corporate
      Organization

    

    a. ATG
      is a
      corporation duly organized, validly existing and in good standing under the
      laws
      of Delaware, and has all requisite corporate power and authority to own its
      properties and assets and to conduct its business as now conducted and is duly
      qualified to do business in good standing in each jurisdiction in which the
      nature of the business conducted by ATG or the ownership or leasing of its
      properties makes such qualification and being in good standing necessary, except
      where the failure to be so qualified and in good standing will not have a
      material adverse effect on the business, operations, properties, assets,
      condition or results of operation of ATG (a "ATG
      Material Adverse Effect");
      

    

    b. Copies
      of
      the Articles of Incorporation and By-laws of ATG as well as the Certificates
      of
      Designation of the Series A Stock and the Series A Stock, with all amendments
      thereto to the date hereof, have been furnished to KAL, and such copies are
      accurate and complete as of the date hereof. The minute books of ATG are current
      as required by law, contain the minutes of all meetings of the Board of
      Directors and shareholders of ATG from its date of incorporation to the date
      of
      this Agreement, and adequately reflect all material actions taken by the Board
      of Directors and shareholders of ATG.

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    Section
      2.2 Capitalization
      of ATG.
      The
      authorized capital stock of ATG consists of (a) a total of 200,000,000 shares
      of
      Common Stock, par value $.0001 per share, 243,999 shares of which are issued
      and
      outstanding, (b) 10,000,000 shares of Preferred Stock, $.001 par value per
      share
      (the “Preferred
      Stock”),
      none
      of which has been issued and outstanding, but 7,500,000 shares shall have been
      designated as Series A Senior Convertible Preferred Stock (“Series
      A Stock”).
      The
      parties agree that they have been informed of the issuances of the ATG Shares,
      and that all such issuances of ATG Shares pursuant to this Agreement will be
      in
      accordance with the provisions of this Agreement. All of the ATG Shares to
      be
      issued pursuant to this Agreement have been duly authorized and will be validly
      issued, fully paid and non-assessable and no personal liability will attach
      to
      the ownership thereof. Except as pursuant to the Financing Transaction, as
      of
      the date of this Agreement there are and as of the Closing Date, there will
      be,
      no outstanding options, warrants, agreements, commitments, conversion rights,
      preemptive rights or other rights to subscribe for, purchase or otherwise
      acquire any shares of capital stock or any un-issued or treasury shares of
      capital stock of ATG. 

    

    Section
      2.3 Subsidiaries
      and Equity Investments.
      ATG
      represents and warrants that (i) set forth on Schedule 2.3
      is a
      true and correct list of the entities in which ATG, directly or indirectly,
      owns
      capital stock or holds an equity or similar interest, together with their
      respective jurisdictions of organization and the percentage of the outstanding
      capital stock or other equity interests of such entity that is held by ATG;
      (ii)
      other than with respect to the entities listed on Schedule 2.3,
      ATG
      does not, directly or indirectly, own any securities or beneficial ownership
      interests in any other Person (including through joint ventures or partnership
      arrangements) or have any investment in any other Person; (iii) ATG and its
      “Subsidiaries”
(which
      for purposes of this Agreement means any entity in which ATG or any of its
      Subsidiaries, directly or indirectly, owns any of the capital stock, equity
      or
      similar interests or voting power of such entity at the date of this Agreement)
      are entities duly organized and
      validly existing and, except as set forth on Schedule
      2.3,
      in good
      standing under the laws of the jurisdictions in which they are formed, and
      have
      the requisite power and authority to own their properties and to carry on their
      business as now being conducted; and (iv) if applicable, each of ATG and the
      Subsidiaries is duly qualified as a foreign entity to do business and, to the
      extent legally applicable, is in good standing in every jurisdiction in which
      its ownership of property or the nature of the business conducted by it makes
      such qualification necessary, except to the extent that the failure to be so
      qualified or be in good standing would not have a material adverse
      effect

    

    Section
      2.4 Authorization
      and Validity of Agreements.
      ATG has
      all corporate power and authority to execute and deliver this Agreement, to
      perform its obligations hereunder and to consummate the transactions
      contemplated hereby. The execution and delivery of this Agreement by ATG and
      the
      consummation by ATG of the transactions contemplated hereby have been duly
      authorized by all necessary corporate action of ATG, and no other corporate
      proceedings on the part of ATG are necessary to authorize this Agreement or
      to
      consummate the transactions contemplated hereby.

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    Section 2.5 No
      Conflict or Violation.
      The
      execution and delivery by such party of this Agreement does not, and the
      performance by ATG of its obligations under this Agreement and the consummation
      of the transactions contemplated hereby will not, conflict with or result in
      a
      violation or breach of any of the terms, conditions or provisions of any other
      agreement to which ATG is a party. Neither ATG, nor any subsidiary, is in
      violation of, in conflict with, in breach of or in default under any term or
      provision of, and no right of any party to accelerate, terminate, modify or
      cancel has come into existence under, (i) its articles of incorporation or
      by-laws (each as may have been amended, supplemented or restated), (ii) any
      provision of any judgment, writ, injunction, decree or order to which the any
      of
      them is a party; or (iii) any law, statute, rule or regulation applicable to
      any
      of them.

    

    Section
      2.6 Consents
      and Approvals.
      No
      consent, waiver, authorization or approval of any governmental or regulatory
      authority, domestic or foreign, or of any other person, firm or corporation,
      is
      required in connection with the execution and delivery of this Agreement by
      ATG
      or the performance by ATG of its obligations hereunder.

    

    Section
      2.7 Material
      Agreements.
      ATG
      represents that ATG is not a party to or bound by any contracts, including,
      but
      not limited to any:

    

    
      	
            	a.	
              employment,
                advisory or consulting contract;

            

    

    

    
      	
            	b.	
              plan
                providing for employee benefits of any
                nature;

            

    

    

    
      	
            	c.	
              lease
                with respect to any property or
                equipment;

            

    

    

    
      	 	
              d.

            	
              contract,
                agreement, understanding or commitment for any future expenditure
                in
                excess of $1,000 in the aggregate;

            

    

    

    
      	 	
              e.

            	
              contract
                or commitment pursuant to which it has assumed, guaranteed, endorsed,
                or
                otherwise become liable for any obligation of any other person, entity
                or
                organization;

            

    

    

    
      	 	
              f.

            	
              agreement
                with any person relating to the dividend, purchase or sale of securities,
                that has not been settled by the delivery or payment of securities
                when
                due, and which remains unsettled upon the date of the
                Agreement.

            

    

    

     Section
      2.8 No
      Disagreements with Accountants and Lawyers.
      ATG
      represents that there are no disagreements of any kind presently existing,
      or
      anticipated by ATG to arise, between ATG accountants and lawyers formerly or
      presently employed by ATG. ATG is current with respect to fees owed to its
      accountants and lawyers.

    

    Section
      2.9 Disclosure.
      This
      Agreement and any certificate attached hereto or delivered in accordance with
      the terms hereby by or on behalf of ATG in connection with the transactions
      contemplated by this Agreement, when taken together, do not contain any untrue
      statement of a material fact or omit any material fact necessary in order to
      make the statements contained herein and/or therein not misleading.

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    Section
      2.10  Litigation.
      ATG
      represents that (i) there is no action, suit, proceeding or investigation
      pending or, to the best knowledge of ATG, currently threatened against ATG
      or
      any Subsidiary that may affect the validity of this Agreement or the right
      of
      the Sellers to enter into this Agreement or to consummate the transactions
      contemplated hereby; (ii) there is no action, suit, proceeding or investigation
      pending or, to the best knowledge of ATG, currently threatened against ATG
      or
      its Subsidiaries, before any court or by or before any governmental body or
      any
      arbitration board or tribunal, nor is there any judgment, decree, injunction
      or
      order of any court, governmental department, commission, agency, instrumentality
      or arbitrator against ATG or any of its Subsidiaries; (iii) ATG and its
      Subsidiaries are not a party or subject to the provisions of any order, writ,
      injunction, judgment or decree of any court or government agency or
      instrumentality; and (iv) there is no action, suit, proceeding or investigation
      by ATG or any Subsidiary currently pending or which ATG intends to initiate.
      When any reference to the “knowledge” or “best knowledge” of ATG, CA or Sellers
      is made in this Agreement, such terms shall mean the knowledge that would be
      gained from due inquiry into the matters referenced.

    

    Section
      2.11 Financial
      Statements and SEC Filings.
      a. ATG
      represents that (i) ATG’s financial statements contained in its periodic reports
      filed with the Securities and Exchange Commission (the “Financial
      Statements”)
      have
      been prepared in accordance with generally accepted accounting principles
      applicable in the United States of America (“U.S.
      GAAP”)
      applied
      on a consistent basis throughout the periods indicated and with each other,
      except that the unaudited Financial Statements do not contain all footnotes
      required by U.S. GAAP; (ii) the Financial Statements fairly present the
      financial condition and operating results of ATG as of the dates, and for the
      periods, indicated therein, subject to normal year-end audit adjustments; (iii)
      except as set forth in the Financial Statements, ATG has no material liabilities
      (contingent or otherwise); (iii) ATG is not a guarantor or indemnitor of any
      indebtedness of any other person, firm or corporation; and (iv) ATG maintains
      and will continue to maintain a standard system of accounting established and
      administered in accordance with U.S. GAAP until Closing. 

    

    b.
      (i)
      ATG has timely made all filings with the SEC that it has been required to make
      under the Securities Act and the Exchange Act ( the “Public
      Reports”).
      Each
      of the Public Reports has complied in all material respects with the applicable
      provisions of the Securities Act, the Exchange Act, and the Sarbanes/Oxley
      Act
      of 2002 (the “Sarbanes/Oxley
      Act”)
      and/or
      regulations promulgated thereunder. None of the Public Reports, as of their
      respective dates, contained any untrue statement of a material fact or omitted
      to state a material fact necessary to make the statements made therein not
      misleading. To the knowledge of ATG or the ATG Controlling Shareholders, there
      is no event, fact or circumstance that would cause any certification signed
      by
      any officer of ATG in connection with any Public Report pursuant to the
      Sarbanes/Oxley Act to be untrue, inaccurate or incorrect in any respect. There
      is no revocation order, suspension order, injunction or other proceeding or
      law
      affecting the trading of its Common Stock. The consummation of the transactions
      contemplated by this Agreement do not conflict with and will not result in
      any
      violation of any FINRA or OTC Bulletin Board trading requirement or standard
      applicable to ATG or its Common Stock. All of the issued and outstanding shares
      of Common Stock have been issued in compliance with the Securities Act and
      applicable state securities laws and no stockholder of ATG has any right to
      rescind or other claim against ATG for failure to comply with the Securities
      Act
      or state securities laws.

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

    (ii)
       Since
      the
      date of the filing of its annual report on Form 10-KSB for the year ended
      January 31, 2008, except as specifically disclosed in the Public Reports: (A)
      there has been no event, occurrence or development that has resulted in or
      could
      result in a Material Adverse Effect (for purposes of this Section 2.11, a
“Material Adverse Effect” means any event, occurrence, fact, condition, change
      or effect that is materially adverse to the business, assets, condition
      (financial or otherwise), operating results or prospects of ATG); (B) ATG has
      not incurred any liabilities, contingent or otherwise, other than professional
      fees, which are accurately disclosed in the Public Reports; (C) ATG has not
      declared or made any dividend or distribution of cash or property to its
      shareholders, purchased, redeemed or made any agreements to purchase or redeem
      any shares of its capital stock, or issued any equity securities; and (D) ATG
      has not made any loan, advance or capital contribution to or investment in
      any
      person or entity. 

    

    Section
      2.12 Books
      and Financial Records.
      ATG
      represents that all the accounts, books, registers, ledgers, Board minutes
      and
      financial and other material records of whatsoever kind of each of ATG and
      its
      Subsidiaries have been fully properly and accurately kept and completed; there
      are no material inaccuracies or discrepancies of any kind contained or reflected
      therein; and they give and reflect a true and fair view of the financial,
      contractual and legal position of each company.

    

    Section
      2.13 Employee
      Benefit Plans.
      ATG
      represents that the Company does not have any “Employee Benefit Plan” as defined
      in the U.S. Employee Retirement Income Security Act of 1974 or similar plans
      under applicable laws.

    

    Section
      2.14 Tax
      Returns, Payments and Elections.
      ATG
      represents that (i) each of ATG and its Subsidiaries has timely filed all Tax
      (as defined below) returns, statements, reports, declarations and other forms
      and documents (including, without limitation, estimated tax returns and reports
      and material information returns and reports) (“Tax
      Returns”)
      required pursuant to applicable law to be filed with any Tax Authority (as
      defined below) (ii) all such Tax Returns are accurate, complete and correct
      in
      all material respects, and each of ATG and its Subsidiaries has timely paid
      all
      Taxes due; and (iii) each of ATG and its Subsidiaries has withheld or collected
      from each payment made to each of its employees, the amount of all Taxes
      (including, but not limited to, United States income taxes and other foreign
      taxes) required to be withheld or collected therefrom, and has paid the same
      to
      the proper Tax Authority. For purposes of this Agreement, the following terms
      have the following meanings: “Tax”
(and,
      with correlative meaning, “Taxes” and “Taxable”) means any and all taxes
      including, without limitation, (x) any net income, alternative or add-on minimum
      tax, gross income, gross receipts, sales, use, ad valorem, transfer, franchise,
      profits, value added, net worth, license, withholding, payroll, employment,
      excise, severance, stamp, occupation, premium, property, environmental or
      windfall profit tax, custom, duty or other tax, governmental fee or other like
      assessment or charge of any kind whatsoever, together with any interest or
      any
      penalty, addition to tax or additional amount imposed by any United States,
      local or foreign governmental authority or regulatory body responsible for
      the
      imposition of any such tax (domestic or foreign) (a “Tax
      Authority”),
      (y)
      any liability for the payment of any amounts of the type described in (x) as
      a
      result of being a member of an affiliated, consolidated, combined or unitary
      group for any taxable period or as the result of being a transferee or successor
      thereof and (z) any liability for the payment of any amounts of the type
      described in (x) or (y) as a result of any express or implied obligation to
      indemnify any other person. 

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

    Section
      2.15 Survival.
      Each of
      the representations and warranties set forth in this Article II shall be deemed
      represented and made by ATG at the Closing as if made at such time and shall
      survive the Closing for a period terminating on the second anniversary of the
      date of this Agreement.

    

    ARTICLE
      III

    

    REPRESENTATIONS
      AND WARRANTIES OF ABM AND KAL

     

    Unless
      otherwise indicated below, ABM and KAL, severally and not jointly, represents,
      warrants and agrees, as to itself, that the statements in the following
      paragraphs of this Section 3 are all true and complete as of the date hereof,
      and will, except as contemplated by this Agreement, be true and complete as
      of
      the Closing Date as if first made on such date:

    

    Section
      3.1 Corporate
      Organization.
       ABM
      is a
      company organized as a BVI Business Company under the laws of the British Virgin
      Islands, is duly organized, validly existing and in good standing under the
      laws
      of the British Virgin Islands and has the requisite power and authority to
      own,
      lease and operate its assets and properties and to carry on its business as
      it
      is now being or currently planned to be conducted. ABM is in possession of
      all
      franchises, grants, authorizations, licenses, permits, easements, consents,
      certificates, approvals and orders (“Approvals”)
      necessary to own, lease and operate the properties it purports to own, operate
      or lease and to carry on its business as it is now being conducted, and to
      consummate the transactions contemplated under this Agreement, except where
      the
      failure to have such Approvals could not, individually or in the aggregate,
      reasonably be expected to have a material adverse effect on the business,
      operations, properties, assets, condition or results of operation of ABM. ABM
      has complete and correct copies of the articles of organization and bylaws
      or
      similar governing, organization or charter documents (collectively referred
      to
      herein as "Charter
      Documents").
      ABM
      is not in violation of any of the provisions of its Charter Documents. The
      minute books or the equivalent of ABM contain true, complete and accurate
      records of meetings and consents in lieu of meetings of its board of directors
      (and any committees thereof), similar governing bodies and stockholders of
      ABM
      ("Corporate
      Records"),
      since
      the time of its organization. The ownership records of ABM Shares are true,
      complete and accurate records of the ownership of the ABM Shares as of the
      date
      of such records and contain all transfers of such Shares since the time of
      ABM’s
      organization (“Share Records”).  

    

    Section
      3.2 Capitalization
      of ABM; Title to the ABM Shares.
      On the
      Closing Date, immediately before the transactions to be consummated pursuant
      to
      this Agreement, ABM shall have authorized 50,000 shares of capital stock,
      US$1.00 per share, of which one (1) ABM Share will be issued and outstanding.
      The ABM Share is the sole outstanding share of capital stock of ABM, and there
      are no outstanding options, warrants, agreements, commitments, conversion
      rights, preemptive rights or other rights to subscribe for, purchase or
      otherwise acquire any shares of capital stock or any un-issued or treasury
      shares of capital stock of ABM.

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

    Section
      3.3 Subsidiaries
      and Equity Investments; Assets.
      Each of
      the subsidiaries and affiliated companies of ABM are set forth on Schedule
      3.3.

    

    Section
      3.4 Authorization
      and Validity of Agreements.
      ABM has
      all corporate power and authority to execute and deliver this Agreement, to
      perform its obligations hereunder and to consummate the transactions
      contemplated hereby. The execution and delivery of this Agreement by ABM and
      the
      consummation of the transactions contemplated hereby have been duly authorized
      by all necessary corporate action and no other corporate proceedings on the
      part
      of ABM are necessary to authorize this Agreement or to consummate the
      transactions contemplated hereby. KAL has approved this Agreement on behalf
      of
      ABM and no other stockholder approvals are required to consummate the
      transactions contemplated hereby. The execution and delivery of this Agreement
      by KAL and the consummation of the transactions contemplated hereby by KAL
      have
      been duly authorized by all necessary action by KAL and no other proceedings
      on
      the part of ABM or KAL are necessary to authorize this Agreement or to
      consummate the transactions contemplated hereby. 

    

    Section
      3.5 No
      Conflict or Violation.
      The
      execution, delivery and performance of this Agreement by ABM or KAL does not
      and
      will not violate or conflict with any provision of the Charter Documents of
      ABM,
      and does not and will not violate any provision of law, or any order, judgment
      or decree of any court or other governmental or regulatory authority, nor
      violate, result in a breach of or constitute (with due notice or lapse of time
      or both) a default under or give to any other entity any right of termination,
      amendment, acceleration or cancellation of any contract, lease, loan agreement,
      mortgage, security agreement, trust indenture or other agreement or instrument
      to which ABM or KAL is a party or by which it is bound or to which any of its
      respective properties or assets is subject, nor result in the creation or
      imposition of any lien, charge or encumbrance of any kind whatsoever upon any
      of
      the properties or assets of ABM or KAL, nor result in the cancellation,
      modification, revocation or suspension of any of the licenses, franchises,
      permits to which ABM or KAL is bound.

    

    Section
      3.6 Investment
      Representations.
      

    

    (a)
      The
      ATG Shares will be acquired hereunder solely for the account of KAL, for
      investment, and not with a view to the resale or distribution thereof. KAL
      understands and is able to bear any economic risks associated with such
      investment in the ATG Shares. KAL has had full access to all the information
      it
      considers necessary or appropriate to make an informed investment decision
      with
      respect to the ATG Shares to be acquired under this Agreement. KAL is an
“accredited investor” (as such term is defined in Rule 501(a) of Regulation D
      promulgated by the Securities and Exchange Commission under the Securities
      Act).

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

    (b)
      No
      offer to enter into this Agreement has been made by ATG to KAL in the United
      States. None of KAL, any of its affiliate, or any person acting on behalf of
      KAL
      or any behalf of any such affiliate, has engaged or will engage in any activity
      undertaken for the purpose of, or that reasonably could be expected to have
      the
      effect of, conditioning the markets in the United States for the ATG Shares,
      including, but not limited to, effecting any sale or short sale of securities
      through KAL, or any of its affiliate prior to the expiration of any restricted
      period contained in Regulation S promulgated under the Securities Act (any
      such
      activity being defined herein as a “Directed
      Selling Effort”).
      To
      the best knowledge of KAL, this Agreement and the transactions contemplated
      herein are not part of a plan or scheme to evade the registration provisions
      of
      the Securities Act, and the ATG Shares are being acquired for investment
      purposes by KAL. KAL agrees that all offers and sales of ATG Shares from the
      date hereof and through the expiration of the any restricted period set forth
      in
      Rule 903 of Regulation S (as the same may be amended from time to time
      hereafter) shall not be made to U.S. Persons or for the account or benefit
      of
      U.S. Persons and shall otherwise be made in compliance with the provisions
      of
      Regulation S and any other applicable provisions of the Securities Act. Neither
      KAL nor the representatives of KAL have conducted any Directed Selling Effort
      as
      that term is used and defined in Rule 902 of Regulation S and neither KAL nor
      any representative of KAL will engage in any such Directed Selling Effort within
      the United States through the expiration of any restricted period set forth
      in
      Rule 903 of Regulation S.

    

    Section
      3.7 Brokers’
      Fees. KAL
      does
      not have any liability to pay any fees or commissions or other consideration
      to
      any broker, finder, or agent with respect to the transactions contemplated
      by
      this Agreement. 

    

    Section
      3.8 Disclosure.
      This
      Agreement, the schedules hereto and any certificate attached hereto or delivered
      in accordance with the terms hereby by or on behalf of ABM or KAL in connection
      with the transactions contemplated by this Agreement, when taken together,
      do
      not contain any untrue statement of a material fact or omit any material fact
      necessary in order to make the statements contained herein and/or therein not
      misleading. 

    

    Section
      3.9 Survival.
      Each of
      the representations and warranties set forth in this Article III shall be deemed
      represented and made by ABM and KAL at the Closing as if made at such time
      and
      shall survive the Closing for a period terminating on the second anniversary
      of
      the date of this Agreement.

    

    ARTICLE
      IV

    

    COVENANTS

    

    Section
      4.1 Certain
      Changes and Conduct of Business.

    

    a. From
      and
      after the date of this Agreement and until the Closing Date, ATG shall conduct
      its business solely in the ordinary course consistent with past practices and,
      in a manner consistent with all representations, warranties or covenants of
      ATG,
      and without the prior written consent of ABM, will not, except as required
      or
      permitted pursuant to the terms hereof and the Financing
      Transaction:

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

    
      	 	
              i.

            	
              make
                any material change in the conduct of its businesses and/or operations
                or
                enter into any transaction other than in the ordinary course of business
                consistent with past practices;

            

    

    

    
      	 	
              ii.

            	
              make
                any change in its Charter Documents; issue any additional shares
                of
                capital stock or equity securities or grant any option, warrant or
                right
                to acquire any capital stock or equity securities or issue any security
                convertible into or exchangeable for its capital stock or alter in
                any
                material term of any of its outstanding securities or make any change
                in
                its outstanding shares of capital stock or its capitalization, whether
                by
                reason of a reclassification, recapitalization, stock split or
                combination, exchange or readjustment of shares, stock dividend or
                otherwise;

            

    

    

    
      	 	
              iii.

            	
              A.

            	
              incur,
                assume or guarantee any indebtedness for borrowed money, issue any
                notes,
                bonds, debentures or other corporate securities or grant any option,
                warrant or right to purchase any thereof, except pursuant to transactions
                in the ordinary course of business consistent with past practices;
                or

            

    

    

    B. issue
      any
      securities convertible or exchangeable for debt or equity securities of
      ATG;

    

    
      	 	
              iv.

            	
              make
                any sale, assignment, transfer, abandonment or other conveyance of
                any of
                its assets or any part thereof, except pursuant to transactions in
                the
                ordinary course of business consistent with past
                practice;

            

    

    

    
      	 	
              v.

            	
              subject
                any of its assets, or any part thereof, to any lien or suffer such
                to be
                imposed other than such liens as may arise in the ordinary course
                of
                business consistent with past practices by operation of law which
                will not
                have an ATG Material Adverse
                Effect;

            

    

    

    
      	 	
              vi.

            	
              acquire
                any assets, raw materials or properties, or enter into any other
                transaction, other than in the ordinary course of business consistent
                with
                past practices;

            

    

    

    
      	 	
              vii.

            	
              enter
                into any new (or amend any existing) employee benefit plan, program
                or
                arrangement or any new (or amend any existing) employment, severance
                or
                consulting agreement, grant any general increase in the compensation
                of
                officers or employees (including any such increase pursuant to any
                bonus,
                pension, profit-sharing or other plan or commitment) or grant any
                increase
                in the compensation payable or to become payable to any employee,
                except
                in accordance with pre-existing contractual provisions or consistent
                with
                past practices;

            

    

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

    
      	 	
              viii.

            	
              make
                or commit to make any material capital
                expenditures;

            

    

    

    
      	 	
              ix.

            	
              pay,
                loan or advance any amount to, or sell, transfer or lease any properties
                or assets to, or enter into any agreement or arrangement with, any
                of its
                affiliates;

            

    

    

    
      	 	
              x.

            	
              guarantee
                any indebtedness for borrowed money or any other obligation of any
                other
                person;

            

    

    

    
      	 	
              xi.

            	
              fail
                to keep in full force and effect insurance comparable in amount and
                scope
                to coverage maintained by it (or on behalf of it) on the date
                hereof;

            

    

    

    
      	 	
              xii.

            	
              take
                any other action that would cause any of the representations and
                warranties made by it in this Agreement not to remain true and correct
                in
                all material aspect;

            

    

    

    
      	 	
              xiii.

            	
              make
                any material loan, advance or capital contribution to or investment
                in any
                person;

            

    

    

    
      	 	
              xiv.

            	
              make
                any material change in any method of accounting or accounting principle,
                method, estimate or practice;

            

    

    

    
      	 	
              xv.

            	
              settle,
                release or forgive any claim or litigation or waive any
                right;

            

    

    

    
      	 	
              xvi.

            	
              commit
                itself to do any of the foregoing.

            

    

    

    b. From
      and
      after the date of this Agreement, ABM will:

    

    
      	 	
              1.

            	
              continue
                to maintain, in all material respects, its properties in accordance
                with
                present practices in a condition suitable for its current
                use;

            

    

    

    
      	 	
              2.

            	
              file,
                when due or required, federal, state, foreign and other tax returns
                and
                other reports required to be filed and pay when due all taxes,
                assessments, fees and other charges lawfully levied or assessed against
                it, unless the validity thereof is contested in good faith and by
                appropriate proceedings diligently
                conducted;

            

    

    

    
      	 	
              3.

            	
              continue
                to conduct its business in the ordinary course consistent with past
                practices;

            

    

    

    
      	 	
              4.

            	
              keep
                its books of account, records and files in the ordinary course and
                in
                accordance with existing practices;
                and

            

    

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

    
      	 	
              5.

            	
              continue
                to maintain existing business relationships with suppliers.
                

            

    

    

    Section
      4.2 Access
      to Properties and Records.
      ABM
      shall afford ATG’s accountants, counsel and authorized representatives, and ATG
      shall afford to ABM's accountants, counsel and authorized representatives full
      access during normal business hours throughout the period prior to the Closing
      Date (or the earlier termination of this Agreement) to all of such parties’
properties, books, contracts, commitments and records and, during such period,
      shall furnish promptly to the requesting party all other information concerning
      the other party's business, properties and personnel as the requesting party
      may
      reasonably request, provided that no investigation or receipt of information
      pursuant to this Section 4.2 shall affect any representation or warranty of
      or
      the conditions to the obligations of any party. 

    

    Section
      4.3 Negotiations.
      From
      and after the date hereof until the earlier of the Closing or the termination
      of
      this Agreement, no party to this Agreement nor its officers or directors
      (subject to such director's fiduciary duties) nor anyone acting on behalf of
      any
      party or other persons shall, directly or indirectly, encourage, solicit, engage
      in discussions or negotiations with, or provide any information to, any person,
      firm, or other entity or group concerning any merger, sale of substantial
      assets, purchase or sale of shares of capital stock or similar transaction
      involving any party except for the Financing Transaction. A party shall promptly
      communicate to any other party any inquiries or communications concerning any
      such transaction which they may receive or of which they may become aware
      of.

    

    Section
      4.4 Consents
      and Approvals.
      The
      parties shall:

    

    
      	 	
              i.

            	
              use
                their reasonable commercial efforts to obtain all necessary consents,
                waivers, authorizations and approvals of all governmental and regulatory
                authorities, domestic and foreign, and of all other persons, firms
                or
                corporations required in connection with the execution, delivery
                and
                performance by them of this Agreement; and

            

    

    

    
      	 	
              ii.

            	
              diligently
                assist and cooperate with each party in preparing and filing all
                documents
                required to be submitted by a party to any governmental or regulatory
                authority, domestic or foreign, in connection with such transactions
                and
                in obtaining any governmental consents, waivers, authorizations or
                approvals which may be required to be obtained connection in with
                such
                transactions.

            

    

    

    Section
      4.5 Public
      Announcement.
      Unless
      otherwise required by applicable law, the parties hereto shall consult with
      each
      other before issuing any press release or otherwise making any public statements
      with respect to this Agreement and shall not issue any such press release or
      make any such public statement prior to such consultation.

    
      
        
        

      

      
        13

        
          

        

      

      
        
        

      

    

    Section
      4.6 Stock
      Issuance.
      From
      and after the date of this Agreement until the Closing Date, neither ATG nor
      ABM
      shall issue any additional shares of its capital stock, except that ATG may
      issue up to an aggregate of 4,008,188 shares of Series A Stock to certain
      accredited investors in the Financing Transaction pursuant to the terms of
      a
      Securities Purchase Agreement by and among ATG and such investors to be entered
      into on the Closing Date, a draft of which agreement is attached hereto as
      Exhibit A. 

    

    Section
      4.7 Notwithstanding
      anything to the contrary contained herein, it is herewith understood and agreed
      that both ABM and ATG may enter into and conclude agreements and/or financing
      transactions as same relate to and/or are contemplated by any separate written
      agreements either: (a) as part of or in connection with the Financing
      Transaction, (b) annexed hereto as exhibits; or (c) entered into by ATG with
      ABM
      executed by both parties subsequent to the date hereof. These Agreements shall
      become, immediately upon execution, part of this Agreement and subject to all
      warranties, representations and conditions contained herein.

    

    ARTICLE
      V

    

    CONDITIONS
      TO OBLIGATIONS OF ABM AND KAL

    

    The
      obligations of ABM and KAL to consummate the transactions contemplated by this
      Agreement are subject to the fulfillment, at or before the Closing Date, of
      the
      following conditions, any one or more of which may be waived by both ABM and
      KAL
      in their sole discretion:

    

    Section
      5.1 Representations
      and Warranties of ATG.
      All
      representations and warranties made by ATG in this Agreement shall be true
      and
      correct on and as of the Closing Date as if again made by ATG as of such date.
      

    

    Section
      5.2 Agreements
      and Covenants.
      ATG
      shall have performed and complied in all material respects to all agreements
      and
      covenants required by this Agreement to be performed or complied with by it
      on
      or prior to the Closing Date. 

    

    Section
      5.3 Consents
      and Approvals.
      Consents, waivers, authorizations and approvals of any governmental or
      regulatory authority, domestic or foreign, and of any other person, firm or
      corporation, required in connection with the execution, delivery and performance
      of this Agreement shall be in full force and effect on the Closing
      Date.

    

    Section
      5.4 No
      Violation of Orders.
      No
      preliminary or permanent injunction or other order issued by any court or
      governmental or regulatory authority, domestic or foreign, nor any statute,
      rule, regulation, decree or executive order promulgated or enacted by any
      government or governmental or regulatory authority, which declares this
      Agreement invalid in any respect or prevents the consummation of the
      transactions contemplated hereby, or which materially and adversely affects
      the
      assets, properties, operations, prospects, net income or financial condition
      of
      ATG shall be in effect; and no action or proceeding before any court or
      governmental or regulatory authority, domestic or foreign, shall have been
      instituted or threatened by any government or governmental or regulatory
      authority, domestic or foreign, or by any other person, or entity which seeks
      to
      prevent or delay the consummation of the transactions contemplated by this
      Agreement or which challenges the validity or enforceability of this
      Agreement.

    
      
        
        

      

      
        14

        
          

        

      

      
        
        

      

    

    Section
      5.5 Other
      Closing Documents.
      KAL
      shall have received such other certificates, instruments and documents in
      confirmation of the representations and warranties of ATG or in furtherance
      of
      the transactions contemplated by this Agreement as KAL or its counsel may
      reasonably request.

    

    ARTICLE
      VI

     

    CONDITIONS
      TO OBLIGATIONS OF ATG

    

    The
      obligations of ATG to consummate the transactions contemplated by this Agreement
      are subject to the fulfillment, at or before the Closing Date, of the following
      conditions, any one or more of which may be waived by ATG in its sole
      discretion:

    

    Section
      6.1 Representations
      and Warranties of ABM and KAL.
      All
      representations and warranties made by ABM and KAL in this Agreement shall
      be
      true and correct on and as of the Closing Date as if again made by ABM and
      KAL,
      as applicable, on and as of such date. 

    

    Section
      6.2 Agreements
      and Covenants.
      Each of
      ABM and KAL shall have performed and complied in all material respects to all
      agreements and covenants required by this Agreement to be performed or complied
      with by it on or prior to the Closing Date. 

    

    Section
      6.3 Consents
      and Approvals.
      All
      consents, waivers, authorizations and approvals of any governmental or
      regulatory authority, domestic or foreign, and of any other person, firm or
      corporation, required in connection with the execution, delivery and performance
      of this Agreement, shall have been duly obtained and shall be in full force
      and
      effect on the Closing Date. 

    

    Section
      6.4 No
      Violation of Orders.
      No
      preliminary or permanent injunction or other order issued by any court or other
      governmental or regulatory authority, domestic or foreign, nor any statute,
      rule, regulation, decree or executive order promulgated or enacted by any
      government or governmental or regulatory authority, domestic or foreign, that
      declares this Agreement invalid or unenforceable in any respect or which
      prevents the consummation of the transactions contemplated hereby, or which
      materially and adversely affects the assets, properties, operations, prospects,
      net income or financial condition of ATG, taken as a whole, shall be in effect;
      and no action or proceeding before any court or government or regulatory
      authority, domestic or foreign, shall have been instituted or threatened by
      any
      government or governmental or regulatory authority, domestic or foreign, or
      by
      any other person, or entity which seeks to prevent or delay the consummation
      of
      the transactions contemplated by this Agreement or which challenges the validity
      or enforceability of this Agreement.

    
      
        
        

      

      
        15

        
          

        

      

      
        
        

      

    

    Section
      6.5 Other
      Closing Documents.
      ATG
      shall have received such other certificates, instruments and documents in
      confirmation of the representations and warranties of ABM and/or KAL, as
      applicable, or in furtherance of the transactions contemplated by this Agreement
      as ATG or its counsel may reasonably request.

    

    ARTICLE
      VII

    

    TERMINATION
      AND ABANDONMENT

    

    Section
      7.1 Methods
      of Termination.
      This
      Agreement may be terminated and the transactions contemplated hereby may be
      abandoned at any time before the Closing:

    

    a. By
      the
      mutual written consent of KAL, ABM and ATG;

    

    b. By
      ATG,
      upon a material breach of any representation, warranty, covenant or agreement
      on
      the part of ABM or KAL set forth in this Agreement, or if any representation
      or
      warranty of ABM or KAL shall become untrue, in either case such that any of
      the
      conditions set forth in Article VI hereof would not be satisfied (a
      "ABM/KAL
      Breach"),
      and
      such breach shall, if capable of cure, has not been cured within ten (10) days
      after receipt by the party in breach of a notice from the non-breaching party
      setting forth in detail the nature of such breach;

    

    c. By
      KAL,
      upon a material breach of any representation, warranty, covenant or agreement
      on
      the part of ATG set forth in this Agreement, or, if any representation or
      warranty of ATG shall become untrue, in either case such that any of the
      conditions set forth in Article V hereof would not be satisfied (a "ATG
      Breach"),
      and
      such breach shall, if capable of cure, not have been cured within ten (10)
      days
      after receipt by the party in breach of a written notice from the non-breaching
      party setting forth in detail the nature of such breach;

    

    d. By
      either
      ATG or KAL, if the Closing shall not have consummated before ninety (90) days
      after the date hereof; provided, however, that this Agreement may be extended
      by
      written notice of either KAL or ATG, if the Closing shall not have been
      consummated as a result of ATG or KAL having failed to receive all required
      regulatory approvals or consents with respect to this transaction or as the
      result of the entering of an order as described in this Agreement; and further
      provided, however, that the right to terminate this Agreement under this Section
      7.1(d) shall not be available to any party whose failure to fulfill any
      obligations under this Agreement has been the cause of, or resulted in, the
      failure of the Closing to occur on or before this date.

    
      
        
        

      

      
        16

        
          

        

      

      
        
        

      

    

    e. By
      either
      KAL or ATG if a court of competent jurisdiction or governmental, regulatory
      or
      administrative agency or commission shall have issued an order, decree or ruling
      or taken any other action (which order, decree or ruling the parties hereto
      shall use its best efforts to lift), which permanently restrains, enjoins or
      otherwise prohibits the transactions contemplated by this
      Agreement.

    

    Section
      7.2 Procedure
      Upon Termination.
      In the
      event of termination and abandonment of this Agreement by KAL or ATG pursuant
      to
      Section 7.1, written notice thereof shall forthwith be given to the other
      parties and this Agreement shall terminate and the transactions contemplated
      hereby shall be abandoned, without further action. If this Agreement is
      terminated as provided herein, no party to this Agreement shall have any
      liability or further obligation to any other party to this Agreement; provided,
      however, that no termination of this Agreement pursuant to this Article VII
      shall relieve any party of liability for a breach of any provision of this
      Agreement occurring before such termination.

     

    ARTICLE
      VIII

    

    MISCELLANEOUS
      PROVISIONS

    

    Section
      8.1 Survival
      of Provisions.
      The
      respective representations, warranties, covenants and agreements of each of
      the
      parties to this Agreement (except covenants and agreements which are expressly
      required to be performed and are performed in full on or before the Closing
      Date) shall survive the Closing Date and the consummation of the transactions
      contemplated by this Agreement, subject to Sections 2.14 and 3.9. In the event
      of a breach of any of such representations, warranties or covenants, the party
      to whom such representations, warranties or covenants have been made shall
      have
      all rights and remedies for such breach available to it under the provisions
      of
      this Agreement or otherwise, whether at law or in equity, regardless of any
      disclosure to, or investigation made by or on behalf of such party on or before
      the Closing Date.

    

    Section
      8.2 Publicity.
      No
      party shall cause the publication of any press release or other announcement
      with respect to this Agreement or the transactions contemplated hereby without
      the consent of the other parties, unless a press release or announcement is
      required by law. If any such announcement or other disclosure is required by
      law, the disclosing party agrees to give the non-disclosing parties prior notice
      and an opportunity to comment on the proposed disclosure.

    

    Section
      8.3 Successors
      and Assigns.
      This
      Agreement shall inure to the benefit of, and be binding upon, the parties hereto
      and their respective successors and assigns; provided, however, that no party
      shall assign or delegate any of the obligations created under this Agreement
      without the prior written consent of the other parties. 

    

    Section
      8.4 Fees
      and Expenses.
      Except
      as otherwise expressly provided in this Agreement, all legal and other fees,
      costs and expenses incurred in connection with this Agreement and the
      transactions contemplated hereby shall be paid by the party incurring such
      fees,
      costs or expenses. 

    
      
        
        

      

      
        17

        
          

        

      

      
        
        

      

    

    Section
      8.5 Notices.
      All
      notices and other communications given or made pursuant hereto shall be in
      writing and shall be deemed to have been given or made if in writing and
      delivered personally or sent by registered or certified mail (postage prepaid,
      return receipt requested) to the parties at the following addresses:

    

    If
      to ABM
      or KAL, to:

    

    Shanghai
      Atrip Medical Technology Co., Ltd

    Suite
      1440-6B, Hongqian Road

    Changning
      District

    Shanghai
      

    People’s
      Republic of China

    Attention:
      Chen Zhong, Chairman and CEO

    Tel:
       86-139-1107-9272

    Fax:
       86-459-6046004

    Email: sphiccz@163.net
      

    

    with
      copies to: 

    

    Guzov
      Ofsink, LLC

    600
      Madison Avenue, 14th Floor

    New
      York,
      New York 10022

    Attention:
      Darren Ofsink

    Tel.
      No.:
      (212) 371-8008, ext. 127

    Fax
      No.:
      (212) 688-7273

    

    If
      to
      ATG, to:

    

    Aamaxan
      Transport Group, Inc.

    c/o
      Shanghai Atrip Medical Technology Co., Ltd

    Suite
      1440-6B, Hongqian Road

    Changning
      District

    Shanghai
      

    People’s
      Republic of China

    Attention:
      Chen Zhong, Chairman and CEO

    Tel:
       86-139-1107-9272

    Fax:
       86-459-6046004

    Email: 
      sphiccz@163.net 

    

    with
      copies to: 

    

    Guzov
      Ofsink, LLC

    600
      Madison Avenue, 14th Floor

    New
      York,
      New York 10022

    Attention:
      Darren Ofsink

    Tel.
      No.:
      (212) 371-8008, ext. 127

    Fax
      No.:
      (212) 688-7273

    
      
        
        

      

      
        18

        
          

        

      

      
        
        

      

    

    

    or
      to
      such other persons or at such other addresses as shall be furnished by any
      party
      by like notice to the others, and such notice or communication shall be deemed
      to have been given or made as of the date so delivered or mailed. No change
      in
      any of such addresses shall be effective insofar as notices under this Section
      8.5 are concerned unless such changed address is located in the United States
      of
      America and notice of such change shall have been given to such other party
      hereto as provided in this Section 8.5

    

    Section
      8.6 Entire
      Agreement.
      This
      Agreement, together with the exhibits hereto, represents the entire agreement
      and understanding of the parties with reference to the transactions set forth
      herein and no representations or warranties have been made in connection with
      this Agreement other than those expressly set forth herein or in the exhibits,
      certificates and other documents delivered in accordance herewith. This
      Agreement supersedes all prior negotiations, discussions, correspondence,
      communications, understandings and agreements between the parties relating
      to
      the subject matter of this Agreement and all prior drafts of this Agreement,
      all
      of which are merged into this Agreement. No prior drafts of this Agreement
      and
      no words or phrases from any such prior drafts shall be admissible into evidence
      in any action or suit involving this Agreement.

    

    Section
      8.7 Severability.
      This
      Agreement shall be deemed severable, and the invalidity or unenforceability
      of
      any term or provision hereof shall not affect the validity or enforceability
      of
      this Agreement or of any other term or provision hereof. Furthermore, in lieu
      of
      any such invalid or unenforceable term or provision, the parties hereto intend
      that there shall be added as a part of this Agreement a provision as similar
      in
      terms to such invalid or unenforceable provision as may be possible so as to
      be
      valid and enforceable.

    

    Section
      8.8 Titles
      and Headings.
      The
      Article and Section headings contained in this Agreement are solely for
      convenience of reference and shall not affect the meaning or interpretation
      of
      this Agreement or of any term or provision hereof.

    

    Section
      8.9 Counterparts. This
      Agreement may be executed in two or more counterparts, each of which shall
      be
      deemed an original and all of which together shall be considered one and the
      same agreement.

    

    Section
      8.10 Convenience
      of Forum; Consent to Jurisdiction.
      The
      parties to this Agreement, acting for themselves and for their respective
      successors and assigns, without regard to domicile, citizenship or residence,
      hereby expressly and irrevocably elect as the sole judicial forum for the
      adjudication of any matters arising under or in connection with this Agreement,
      and consent and subject themselves to the jurisdiction of, the courts of the
      State of New York located in County of New York, and/or the United States
      District Court for the Southern District of New York, in respect of any matter
      arising under this Agreement. Service of process, notices and demands of such
      courts may be made upon any party to this Agreement by personal service at
      any
      place where it may be found or giving notice to such party as provided in
      Section 9.5.

    
      
        
        

      

      
        19

        
          

        

      

      
        
        

      

    

    Section
      8.11 Enforcement
      of the Agreement.
      The
      parties hereto agree that irreparable damage would occur if any of the
      provisions of this Agreement were not performed in accordance with their
      specific terms or were otherwise breached. It is accordingly agreed that the
      parties shall be entitled to an injunction or injunctions to prevent breaches
      of
      this Agreement and to enforce specifically the terms and provisions hereto,
      this
      being in addition to any other remedy to which they are entitled at law or
      in
      equity.

    

    Section
      8.12 Governing
      Law.
      This
      Agreement shall be governed by and interpreted and enforced in accordance with
      the laws of the State of New York without giving effect to the choice of law
      provisions thereof.

    

    Section
      8.13 Amendments
      and Waivers.
      No
      amendment of any provision of this Agreement shall be valid unless the same
      shall be in writing and signed by all of the parties hereto.. No waiver by
      any
      party of any default, misrepresentation, or breach of warranty or covenant
      hereunder, whether intentional or not, shall be deemed to extend to any prior
      or
      subsequent default, misrepresentation, or breach of warranty or covenant
      hereunder or affect in any way any rights arising by virtue of any prior or
      subsequent such occurrence.

    
      
        
        

      

      
        20

        
          

        

      

      
        
        

      

    

    IN
      WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
      date
      first above written.

     

    
      	
              KAMICK
                ASSETS LIMITED

            
	 	 
	
              By:

            	
               

            
	
              Name:
                Ganghua Shao

            
	
              Title:
                Director

            
	 	 
	
              ASIAN BUSINESS MANAGEMENT GROUP LIMITED

            
	 	 
	
              By:

            	
               

            
	
              Name:
                Cheng Zhong

            
	
              Title:
                Chairman and CEO

            
	 	 
	
              AAMAXAN
                TRANSPORT GROUP, INC.

            
	 	 
	
              By:

            	
               

            
	
              Name:
                Cheng Zhong

            
	
              Title:
                Chairman and CEO

            

    

    
      
        
        

      

      
        21

        
          

        

      

      
        
        

      

    

    

    EXHIBIT
      A

    

    Securities
      Purchase Agreement

    
      
        
        

      

      
        22

        
          

        

      

      
        
        

      

    

    Schedule
      2.3 

    

    Subsidiaries
      of ATG

    

    None

    
      
        
        

      

      
        23

        
          

        

      

      
        
        

      

    

    Schedule
      3.3

    

    
      	
              Subsidiary
                of ABM

            	
              ABM
                Equity Interest

            
	 	 
	
              Anhante
                (Beijing) Medical Technology Co., Ltd.

            	
              100%

            

      
        
          
          

        

        
          24

          
            

          

        

        
          
          

        

      

    

     

    Schedule
      B

    

    Capitalization
      Table

     

    
      
        
        

      

      
        25SECURITIES
      PURCHASE AGREEMENT

     

    Dated
      as of April 14, 2008

     

    among

     

    AAMAXAN
      TRANSPORT GROUP, INC.

     

    and

     

    THE
      PURCHASERS LISTED ON EXHIBIT A

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    Table
      of
      Contents

    

    
      	
               

            	
               

            	
              Page

            
	
              ARTICLE
                I

            	
              Purchase
                and Sale of Preferred Stock

            	
              1

            
	
               

            	
               

            	
               

            
	
              Section
                1.1

            	
              Purchase
                and Sale of Stock

            	
              1

            
	
               

            	
               

            	
               

            
	
              Section
                1.2

            	
              Warrants

            	
              1

            
	
               

            	
               

            	
               

            
	
              Section
                1.3

            	
              Conversion
                Shares

            	
              1

            
	
               

            	
               

            	
               

            
	
              Section
                1.4

            	
              Purchase
                Price and Closings

            	
              2

            
	
               

            	
               

            	
               

            
	
              Section
                1.5

            	
              Share
                Exchange Transaction

            	
              2

            
	
               

            	
               

            	
               

            
	
              ARTICLE
                II

            	
              Representations
                and Warranties

            	
              3

            
	
               

            	
               

            	
               

            
	
              Section
                2.1

            	
              Representations
                and Warranties of the Company

            	
              3

            
	
               

            	
               

            	
               

            
	
              Section
                2.2

            	
              Representations
                and Warranties of the Purchasers

            	
              14

            
	
               

            	
               

            	
               

            
	
              ARTICLE
                III

            	
              Covenants

            	
              17

            
	
               

            	
               

            	
               

            
	
              Section
                3.1

            	
              Securities
                Compliance

            	
              17

            
	
               

            	
               

            	
               

            
	
              Section
                3.2

            	
              Registration
                and Listing

            	
              17

            
	
               

            	
               

            	
               

            
	
              Section
                3.3

            	
              Compliance
                with Laws

            	
              18

            
	
               

            	
               

            	
               

            
	
              Section
                3.4

            	
              Keeping
                of Records and Books of Account

            	
              18

            
	
               

            	
               

            	
               

            
	
              Section
                3.5

            	
              Reporting
                Requirements

            	
              18

            
	
               

            	
               

            	
               

            
	
              Section
                3.6

            	
              Other
                Agreements

            	
              18

            
	
               

            	
               

            	
               

            
	
              Section
                3.7

            	
              Distributions

            	
              18

            
	
               

            	
               

            	
               

            
	
              Section
                3.8

            	
              Reservation
                of Shares

            	
              18

            
	
               

            	
               

            	
               

            
	
              Section
                3.9

            	
              Transfer
                Agent Instructions

            	
              19

            
	
               

            	
               

            	
               

            
	
              Section
                3.10

            	
              Disposition
                of Assets

            	
              19

            
	
               

            	
               

            	
               

            
	
              Section
                3.11

            	
              Reporting
                Status

            	
              19

            
	
               

            	
               

            	
               

            
	
              Section
                3.12

            	
              Lock-Up
                Agreement

            	
              19

            
	
               

            	
               

            	
               

            
	
              Section
                3.13

            	
              Investor
                and Public Relations Escrow

            	
              20

            
	
               

            	
               

            	
               

            
	
              Section
                3.14

            	
              Integration

            	
              20

            

    

     

    
      
        
        

      

      
        i

        
          

        

      

      
        
        

      

    

     

    Table
      of
      Contents

     

    
      	 	 	
              Page

            
	
              Section
                3.15

            	
              Limitation
                on Issuance of Future Priced Securities

            	
              20

            
	
               

            	
               

            	
               

            
	
              Section
                3.16

            	
              Additional
                Operating Covenants

            	
              20

            
	
               

            	
               

            	
               

            
	
              Section
                3.17

            	
              Subsequent
                Financings

            	
              22

            
	
               

            	
               

            	
               

            
	
              Section
                3.18

            	
              Sarbanes
                Oxley Act

            	
              25

            
	
               

            	
               

            	
               

            
	
              Section
                3.19

            	
              No
                Commissions in connection with Conversion of Preferred
                Shares

            	
              25

            
	
               

            	
               

            	
               

            
	
              ARTICLE
                IV

            	
              CONDITIONS

            	
              25

            
	
               

            	
               

            	
               

            
	
              Section
                4.1

            	
              Conditions
                Precedent to the Obligation of the Company to Sell the
                Shares

            	
              25

            
	
               

            	
               

            	
               

            
	
              Section
                4.2

            	
              Conditions
                Precedent to the Obligation of the Purchasers to Purchase the
                Units

            	
              26

            
	
               

            	
               

            	
               

            
	
              ARTICLE
                V

            	
              Stock
                Certificate Legend

            	
              28

            
	
               

            	
               

            	
               

            
	
              Section
                5.1

            	
              Legend

            	
              28

            
	
               

            	
               

            	
               

            
	
              ARTICLE
                VI

            	
              Indemnification

            	
              31

            
	
               

            	
               

            	
               

            
	
              Section
                6.1

            	
              General
                Indemnity

            	
              31

            
	
               

            	
               

            	
               

            
	
              Section
                6.2

            	
              Indemnification
                Procedure

            	
              31

            
	
               

            	
               

            	
               

            
	
              ARTICLE
                VII

            	
              Miscellaneous

            	
              32

            
	
               

            	
               

            	
               

            
	
              Section
                7.1

            	
              Fees
                and Expenses

            	
              32

            
	
               

            	
               

            	
               

            
	
              Section
                7.2

            	
              Specific
                Enforcement, Consent to Jurisdiction

            	
              32

            
	
               

            	
               

            	
               

            
	
              Section
                7.3

            	
              Entire
                Agreement; Amendment

            	
              33

            
	
               

            	
               

            	
               

            
	
              Section
                7.4

            	
              Notices

            	
              33

            
	
               

            	
               

            	
               

            
	
              Section
                7.5

            	
              Waivers

            	
              34

            
	
               

            	
               

            	
               

            
	
              Section
                7.6

            	
              Headings

            	
              34

            
	
               

            	
               

            	
               

            
	
              Section
                7.7

            	
              Successors
                and Assigns

            	
              34

            
	
               

            	
               

            	
               

            
	
              Section
                7.8

            	
              No
                Third Party Beneficiaries

            	
              34

            
	
               

            	
               

            	
               

            
	
              Section
                7.9

            	
              Governing
                Law

            	
              34

            

    

     

    
      
        
        

      

      
        ii

        
          

        

      

      
        
        

      

    

     

    Table
      of
      Contents

     

    
      	 	 	
              Page

            
	
              Section
                7.10

            	
              Survival

            	
              34

            
	
               

            	
               

            	
               

            
	
              Section
                7.11

            	
              Counterparts

            	
              34

            
	
               

            	
               

            	
               

            
	
              Section
                7.12

            	
              Publicity

            	
              35

            
	
               

            	
               

            	
               

            
	
              Section
                7.13

            	
              Severability

            	
              35

            
	
               

            	
               

            	
               

            
	
              Section
                7.14

            	
              Further
                Assurances

            	
              35

            

    

     

    
      
        
        

      

      
        iii

        
          

        

      

      
        
        

      

    

     

    SECURITIES
      PURCHASE AGREEMENT

     

    This
      SECURITIES PURCHASE AGREEMENT (the “Agreement”)
      is
      dated as of April 14, 2008 by and among Aamaxan Transport Group, Inc., a
      Delaware corporation (the “Company”),
      and
      each of the Purchasers of Units whose names are set forth on Exhibit
      A
      hereto
      (individually, a “Purchaser”
and
      collectively, the “Purchasers”).

     

    The
      parties hereto agree as follows:

     

    ARTICLE
      I

     

    Purchase
      and Sale of Preferred Stock

     

    Section
      1.1  Purchase
      and Sale of Stock.
      Upon
      the following terms and conditions, the Company shall issue and sell to the
      Purchasers and each of the Purchasers shall purchase from the Company, Units
      (the “Units”),
      each
      consisting of one share of the Company’s Series A Senior Convertible Preferred
      Stock, par value $0.001 per share (the “Preferred
      Shares”),
      convertible into one share of the Company’s common stock, par value $0.0001 per
      share (the “Common
      Stock”)
      and
      one Series A Warrant (as defined below) to purchase Common Stock, in the amounts
      set forth opposite such Purchaser’s name on Exhibit A hereto. The designation,
      rights, preferences and other terms and provisions of the Series A Senior
      Convertible Preferred Stock are set forth in the Series A Certificate of
      Designation of the Relative Rights and Preferences of the Series A Senior
      Convertible Preferred Stock attached hereto as Exhibit
      B
      (the
“Series
      A Certificate of Designation”).
      The
      Company and the Purchasers are executing and delivering this Agreement in
      accordance with and in reliance upon the exemption from securities registration
      afforded by Rule 506 of Regulation D (“Regulation
      D”)
      as
      promulgated by the United States Securities and Exchange Commission (the
“Commission”)
      under
      the Securities Act of 1933, as amended (the “Securities
      Act”)
      or
      Section 4(2) of the Securities Act.

     

    Section
      1.2  Warrants.
      Upon
      the following terms and conditions and for no additional consideration, (i)
      each
      of the Purchasers shall be issued Series A Warrants, in substantially the form
      attached hereto as Exhibit C-1 (the “Series
      A Warrants”
or
      the
“Warrants”),
      to
      purchase the number of shares of Common Stock equal to Fifty Percent (50.0%)
      of
      the number of shares of Common Stock issuable upon conversion of the Preferred
      Shares purchased by each Purchaser pursuant to the terms of this Agreement,
      as
      set forth opposite such Purchaser’s name on Exhibit A hereto.

     

    Section
      1.3  Conversion
      Shares.
      The
      Company has authorized and has reserved and covenants to continue to reserve,
      free of preemptive rights and other similar contractual rights of stockholders,
      a number of shares of Common Stock equal to one hundred fifty percent (150%)
      of
      the number of shares of Common Stock as shall from time to time be sufficient
      to
      effect the conversion of all of the Preferred Shares and exercise of the
      Warrants then outstanding. Any shares of Common Stock issuable upon conversion
      of the Preferred Shares and exercise of the Warrants (and such shares when
      issued) are herein referred to as the “Conversion
      Shares”
and
      the
“Warrant
      Shares”,
      respectively. The Preferred Shares, the Conversion Shares and the Warrant Shares
      are sometimes collectively referred to as the “Shares”.

     

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

     

    Section
      1.4  Purchase
      Price and Closings.
      Subject
      to the terms and conditions hereof, the Company agrees to issue and sell to
      the
      Purchasers and, in consideration of and in express reliance upon the
      representations, warranties, covenants, terms and conditions of this Agreement,
      the Purchasers, severally but not jointly, agree to purchase the Units for
      an
      aggregate purchase price of $3.11 per Unit (the “Purchase
      Price”).
      The
      initial closing of the purchase and sale of the Units to be acquired by the
      Purchasers from the Company under this Agreement shall take place at the offices
      of Guzov Ofsink, LLC , 600 Madison Avenue, 14th
      Floor,
      New York, NY 10022 (the “Initial
      Closing”)
      at
      2:00 p.m., New York time on such date as the Purchasers and the Company may
      agree upon; provided,
      that
      all of the conditions set forth in Article IV hereof and applicable to the
      Initial Closing shall have been fulfilled or waived in accordance herewith
      (the
“Initial
      Closing Date”).
      The
      Purchasers and the Company acknowledge and agree that the Company may consummate
      the sale of additional Units to Purchasers or other purchasers, on the terms
      set
      forth in this Agreement and the other Transaction Documents (as defined in
      Section 2.1(b) hereof), at a closing or additional closings (each, an
“Additional
      Closing”;
      the Initial Closing and any Additional Closing are also sometimes referred
      to
      herein as a “Closing”),
      all
      of which Additional Closings shall occur not later than June 13, 2008 (the
      date
      of any Additional Closing is hereinafter referred to as an 

     

    Additional
      Closing Date”
and
      the
      Initial Closing Date and any Additional Closing Date are also sometimes referred
      to herein as a “Closing
      Date”).
      Subject to the terms and conditions of this Agreement, at each Closing the
      Company shall deliver or cause to be delivered to each Purchaser (x) a
      certificate for the number of Preferred Shares set forth opposite the name
      of
      such Purchaser on Exhibit A hereto (or as such Exhibit A may be amended to
      add
      additional purchasers at an Additional Closing), (y) its Warrants to purchase
      such number of shares of Common Stock as is set forth opposite the name of
      such
      Purchaser on Exhibit A attached hereto (or as such Exhibit A may be amended
      to
      add additional purchasers at an Additional Closing) and (z) any other documents
      required to be delivered pursuant to Article IV hereof. For the Initial Closing,
      each Purchaser shall deliver its Purchase Price for the number of Units
      purchased by wire transfer to the escrow account pursuant to the Closing Escrow
      Agreement (as hereafter defined). For Additional Closings, each Purchaser shall
      deliver its Purchase Price for the number of Units purchased directly to the
      Company. In addition, the parties acknowledge that Three Hundred Thousand
      Dollars ($300,000) of the Purchase Price funded on the Initial Closing Date
      shall be deposited in an escrow account pursuant to the General Escrow Agreement
      (as hereafter defined) to be used by the Company in connection with investor
      and
      public relations.

     

    Section
      1.5  Share
      Exchange Transaction.
      The
      parties acknowledge that immediately prior to the consummation of the
      transactions contemplated by this Agreement at the Initial Closing, the Company
      will issue not more than 16,607,143 shares of its Common Stock to Kamick Assets
      Limited, a company organized in the British Virgin Islands (“Kamick”),
      pursuant to that certain Share Exchange Agreement dated as of the date hereof
      by
      and among the Company, Asia Business Management Group Limited, a company
      organized in the British Virgin Islands, (“ABM”),
      and
      Kamick (the “Share Exchange Agreement”), and upon the consummation of the
      transactions contemplated by the Share Exchange Agreement (i) Shanghai Anhante
      (Beijing) Medical Technology Co., Ltd. (“WFOE”),
      a
“wholly foreign owned enterprise” organized under the laws of the People’s
      Republic of China (the “PRC”)
      and a
      direct wholly-owned subsidiary of ABM immediately prior to the consummation
      of
      the transactions contemplated by the Share Exchange Agreement, will become
      an
      indirect wholly-owned subsidiary of the Company (the “Share
      Exchange Transaction”)
      and
      (ii) the capital structure of the Company will be as set forth on Schedule
      1.5
      attached hereto.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    ARTICLE
      II

     

    Representations
      and Warranties

     

    Section
      2.1  Representations
      and Warranties of the Company.
      The
      Company hereby represents and warrants to the Purchasers, as of the date hereof
      and the Closing Date (except as set forth on the Schedule of Exceptions attached
      hereto with each numbered Schedule corresponding to the section number herein),
      as follows:

     

    (a)  Organization,
      Good Standing and Power.
      The
      Company is a corporation duly incorporated, validly existing and in good
      standing under the laws of the State of Delaware and has the requisite corporate
      power to own, lease and operate its properties and assets and to conduct its
      business as it is now being conducted. The Company does not have any
      subsidiaries except as set forth in the Company’s Form 10-KSB for the year ended
      January 31, 2008, including the accompanying financial statements (the
“Form
      10-KSB”).
      or as
      set forth in Schedule 2.1(g). Except as set forth on Schedule
      2.1(a),
      the
      Company and each such subsidiary is duly qualified as a foreign corporation
      to
      do business and is in good standing in every jurisdiction in which the nature
      of
      the business conducted or property owned by it makes such qualification
      necessary except for any jurisdiction(s) (alone or in the aggregate) in which
      the failure to be so qualified will not have a Material Adverse Effect (as
      defined in Section 2.1(c) hereof) on the Company’s financial
      condition.

     

    (b)  Authorization;
      Enforcement.
      The
      Company has the requisite corporate power and authority to enter into and
      perform this Agreement, the Registration Rights Agreement in the form attached
      hereto as Exhibit
      D
      (the
“Registration
      Rights Agreement”),
      the
      Lock-Up Agreement (as defined in Section 3.12 hereof) in the form attached
      hereto as Exhibit
      E,
      the
      General Escrow Agreement by and among the Company, the Purchasers and the escrow
      agent named therein, dated as of the date hereof, substantially in the form
      of
Exhibit
      F-1
      attached
      hereto (the “General
      Escrow Agreement”)
      the
      Securities Escrow Agreement by and among the Company, the Purchasers and the
      escrow agent named therein, dated as of the date hereof, substantially in the
      form of Exhibit
      F-2
      attached
      hereto (the “Securities
      Escrow Agreement”)
      and
      the Closing Escrow Agreement among the Company, the Purchasers and the escrow
      agent named therein, dated as of the date hereof, in the form of Exhibit
      F-3
      attached
      hereto (the “Closing
      Escrow Agreement”)(and
      together with the General Escrow Agreement and Securities Escrow Agreement,
      the
“Escrow
      Agreements”),
      the
      Irrevocable Transfer Agent Instructions (as defined in Section 3.9), the Series
      A Certificate of Designation, and the Warrants (collectively, the “Transaction
      Documents”)
      and to
      issue and sell the Units, the Shares and the Warrants in accordance with the
      terms hereof. The execution, delivery and performance of the Transaction
      Documents by the Company and the consummation by it of the transactions
      contemplated hereby and thereby have been duly and validly authorized by all
      necessary corporate action, and no further consent or authorization of the
      Company or its Board of Directors or stockholders is required. This Agreement
      has been duly executed and delivered by the Company. The other Transaction
      Documents will have been duly executed and delivered by the Company at the
      Closing. Each of the Transaction Documents constitutes, or shall constitute
      when
      executed and delivered, a valid and binding obligation of the Company
      enforceable against the Company in accordance with its terms, except as such
      enforceability may be limited by applicable bankruptcy, insolvency,
      reorganization, moratorium, liquidation, conservatorship, receivership or
      similar laws relating to, or affecting generally the enforcement of, creditor’s
      rights and remedies or by other equitable principles of general
      application.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    (c)  Capitalization.
      The
      authorized capital stock of the Company and the shares thereof currently issued
      and outstanding as of the date hereof are set forth on Schedule
      2.1(c)
      hereto.
      All of the outstanding shares of the Common Stock and the Preferred Shares
      have
      been duly and validly authorized. Except as contemplated by the Transaction
      Documents or as set forth on Schedule
      2.1(c)
      hereto,
      no shares of Common Stock are entitled to preemptive rights or registration
      rights and there are no outstanding options, warrants, scrip, rights to
      subscribe to, call or commitments of any character whatsoever relating to,
      or
      securities or rights convertible into, any shares of capital stock of the
      Company. Except as contemplated by the Transaction Documents, there are no
      contracts, commitments, understandings, or arrangements by which the Company
      is
      or may become bound to issue additional shares of the capital stock of the
      Company or options, securities or rights convertible into shares of capital
      stock of the Company. Except as contemplated by the Transaction Documents or
      as
      set forth on Schedule
      2.1(c)
      hereto,
      the Company is not a party to any agreement granting registration or
      anti-dilution rights to any person with respect to any of its equity or debt
      securities. The Company is not a party to, and it has no knowledge of, any
      agreement restricting the voting or transfer of any shares of the capital stock
      of the Company. The offer and sale of all capital stock, convertible securities,
      rights, warrants, or options of the Company issued prior to the Closing complied
      with all applicable Federal and state securities laws, and no stockholder has
      a
      right of rescission or claim for damages with respect thereto which would have
      a
      Material Adverse Effect (as defined below). The Company has furnished or made
      available to the Purchasers true and correct copies of the Company’s Articles of
      Incorporation as in effect on the date hereof (the “Articles”),
      and
      the Company’s Bylaws as in effect on the date hereof (the “Bylaws”).
      For
      the purposes of this Agreement, “Material
      Adverse Effect”
means
      any material adverse effect on the business, operations, properties, or
      financial condition of the Company and its subsidiaries and/or any condition,
      circumstance, or situation that would prohibit or otherwise materially interfere
      with the ability of the Company to perform any of its obligations under this
      Agreement in any material respect.

     

    (d)  Issuance
      of Shares.
      The
      Units, the Preferred Shares and the Warrants to be issued at the Closing have
      been duly authorized by all necessary corporate action and the Preferred Shares,
      when paid for or issued in accordance with the terms hereof, shall be validly
      issued and outstanding, fully paid and nonassessable and entitled to the rights
      and preferences set forth in the Series A Certificate of Designation. When
      the
      Conversion Shares and the Warrant Shares are issued in accordance with the
      terms
      of the Series A Certificate of Designation and the Warrants, respectively,
      such
      shares will be duly authorized by all necessary corporate action and validly
      issued and outstanding, fully paid and nonassessable, and the holders shall
      be
      entitled to all rights accorded to a holder of Common Stock.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    (e)  No
      Conflicts.
      The
      execution, delivery and performance of the Transaction Documents by the Company
      and the consummation by the Company of the transactions contemplated herein
      and
      therein do not and will not (i) violate any provision of the Company’s Articles
      or Bylaws, (ii) conflict with, or constitute a default (or an event which with
      notice or lapse of time or both would become a default) under, or give to others
      any rights of termination, amendment, acceleration or cancellation of, any
      agreement, mortgage, deed of trust, indenture, note, bond, license, lease
      agreement, instrument or obligation to which the Company is a party or by which
      it or its properties or assets are bound, (iii) create or impose a lien,
      mortgage, security interest, charge or encumbrance of any nature on any property
      of the Company under any agreement or any commitment to which the Company is
      a
      party or by which the Company is bound or by which any of its respective
      properties or assets are bound, or (iv) result in a violation of any federal,
      state, local or foreign statute, rule, regulation, order, judgment or decree
      (including Federal and state securities laws and regulations) applicable to
      the
      Company or any of its subsidiaries or by which any property or asset of the
      Company or any of its subsidiaries are bound or affected, except, in all cases
      other than violations pursuant to clauses (i) and (iv) above, for such
      conflicts, defaults, terminations, amendments, accelerations, cancellations
      and
      violations as would not, individually or in the aggregate, have a Material
      Adverse Effect. The business of the Company and its subsidiaries is not being
      conducted in violation of any laws, ordinances or regulations of any
      governmental entity, except for possible violations which singularly or in
      the
      aggregate do not and will not have a Material Adverse Effect. The Company is
      not
      required under Federal, state or local law, rule or regulation to obtain any
      consent, authorization or order of, or make any filing or registration with,
      any
      court or governmental agency in order for it to execute, deliver or perform
      any
      of its obligations under the Transaction Documents, or issue and sell the
      Preferred Shares, the Warrants, the Conversion Shares and the Warrant Shares
      in
      accordance with the terms hereof or thereof (other than (x) any consent,
      authorization or order that has been obtained as of the date hereof, (y) any
      filing or registration that has been made as of the date hereof or (z) any
      filings which may be required to be made by the Company with the Commission
      or
      state securities administrators subsequent to the Closing; provided,
      that,
      for purposes of the representation made in this sentence, the Company is
      assuming and relying upon the accuracy of the relevant representations and
      agreements of the Purchasers herein.

     

    (f)  Commission
      Documents, Financial Statements.
      The
      Common Stock is currently registered pursuant to Section 12(g) of the Securities
      Exchange Act of 1934, as amended the “Exchange
      Act”),
      and
      the Company has filed all reports, schedules, forms, statements and other
      documents required to be filed by it with the Commission pursuant to the
      reporting requirements of the Exchange Act, including material filed pursuant
      to
      Section 13(a) or 15(d) of the Exchange Act (all of the foregoing including
      filings incorporated by reference therein being referred to herein as the
“Commission
      Documents”).
      At
      the times of their respective filings, the Form 10-KSB and the Form 10-QSBs
      and
      the current report on Form 8-K that is required to be and shall be filed by
      the
      Company within four business days after the Closing Date to disclose the
      transactions contemplated hereby and under the other Transaction Documents
      and
      the transactions contemplated by the Share Exchange Agreement and the
      Entrustment Agreements(as defined in Section 2.1(dd) hereof) (the “Form
      8-K”),
      complied and, in the case of the Form 8-K, will comply in all material respects
      with the requirements of the Exchange Act and the rules and regulations of
      the
      Commission promulgated thereunder and other federal, state and local laws,
      rules
      and regulations applicable to such documents, and, as of respective dates,
      neither the Form 10-KSB nor the Form 10-QSB contained or, in the case of the
      Form 8-K, contain any untrue statement of a material fact or omitted to state
      a
      material fact required to be stated therein or necessary in order to make the
      statements therein, in light of the circumstances under which they were made,
      not misleading. The financial statements of the Company included in the
      Commission Documents comply as to form in all material respects with applicable
      accounting requirements and the published rules and regulations of the
      Commission or other applicable rules and regulations with respect thereto.
      Such
      financial statements have been prepared in accordance with United States
      generally accepted accounting principles (“GAAP”)
      applied on a consistent basis during the periods involved (except (i) as may
      be
      otherwise indicated in such financial statements or the notes thereto or (ii)
      in
      the case of unaudited interim statements, to the extent they may not include
      footnotes or may be condensed or summary statements), and fairly present in
      all
      material respects the financial position of the Company and its subsidiaries
      as
      of the dates thereof and the results of operations and cash flows for the
      periods then ended (subject, in the case of unaudited statements, to normal
      year-end audit adjustments). The Kamick Financial Statements (as defined in
      Section 4.2(t) hereof) comply in all material respects with applicable
      accounting requirements and the rules and regulations of the Commission with
      respect thereto as in effect at the time of filing. The Kamick Financial
      Statements have been prepared in accordance with GAAP applied on a consistent
      basis during the periods involved and fairly present in all material respects,
      the financial conditions and results of Kamick has defined in Section 4.2(t)
      hereof and its subsidiaries as of the dates thereof and the results of
      operations and cash flows for the periods then ended.

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    (g)  Subsidiaries.
      Schedule
      2.1(g)
      hereto
      sets forth each subsidiary of the Company, showing the jurisdiction of its
      incorporation or organization and showing the percentage of each person’s
      ownership. For the purposes of this Agreement, “subsidiary”
shall
      mean any corporation or other entity of which at least a majority of the
      securities or other ownership interest having ordinary voting power (absolutely
      or contingently) for the election of directors or other persons performing
      similar functions are at the time owned directly or indirectly by the Company
      and/or any of its other subsidiaries. All of the outstanding shares of capital
      stock of each subsidiary have been duly authorized and validly issued, and
      are
      fully paid and nonassessable. Other than as contemplated by the Transaction
      Documents, there are no outstanding preemptive, conversion or other rights,
      options, warrants or agreements granted or issued by or binding upon any
      subsidiary for the purchase or acquisition of any shares of capital stock of
      any
      subsidiary or any other securities convertible into, exchangeable for or
      evidencing the rights to subscribe for any shares of such capital stock. Other
      than as contemplated by the Transaction Documents, neither the Company nor
      any
      subsidiary is subject to any obligation (contingent or otherwise) to repurchase
      or otherwise acquire or retire any shares of the capital stock of any subsidiary
      or any convertible securities, rights, warrants or options of the type described
      in the preceding sentence. Neither the Company nor any subsidiary is party
      to,
      nor has any knowledge of, any agreement restricting the voting or transfer
      of
      any shares of the capital stock of any subsidiary, with the exception of the
      Entrustment Agreements(as defined in Section 2.1(dd)(i) below).

     

    (h)  No
      Material Adverse Effect.
      Other
      than as disclosed in the Company’s Commission Documents, since December 31,
      2007, neither the Company nor any of its subsidiaries has experienced or
      suffered any Material Adverse Effect. 

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    (i)  No
      Undisclosed Liabilities.
      Except
      as disclosed in the Form 10-KSB, the Form 10-QSB and the Form 8-K, neither
      the
      Company nor any of its subsidiaries has any liabilities, obligations, claims
      or
      losses (whether liquidated or unliquidated, secured or unsecured, absolute,
      accrued, contingent or otherwise) other than those incurred in the ordinary
      course of the Company’s or its subsidiaries respective businesses since December
      31, 2007 and which, individually or in the aggregate, do not or would not have
      a
      Material Adverse Effect on the Company or its subsidiaries.

     

    (j)  No
      Undisclosed Events or Circumstances.
      To the
      Company’s knowledge, no event or circumstance has occurred or exists with
      respect to the Company or its subsidiaries or their respective businesses,
      properties, prospects, operations or financial condition, which, under
      applicable law, rule or regulation, requires public disclosure or announcement
      by the Company but which has not been so publicly announced or
      disclosed.

     

    (k)  Indebtedness.
      The
      Form 10-KSB, Form 10-QSB and the Form 8-K set forth all outstanding secured
      and
      unsecured Indebtedness of the Company or any subsidiary, or for which the
      Company or any subsidiary has commitments. For the purposes of this Agreement,
      “Indebtedness”
shall
      mean (a) any liabilities for borrowed money or amounts owed in excess of $50,000
      (other than trade accounts payable incurred in the ordinary course of business),
      (b) all guaranties, endorsements and other contingent obligations in respect
      of
      Indebtedness of others, whether or not the same are or should be reflected
      in
      the Company’s balance sheet (or the notes thereto), except guaranties by
      endorsement of negotiable instruments for deposit or collection or similar
      transactions in the ordinary course of business; and (c) the present value
      of
      any lease payments in excess of $25,000 due under leases required to be
      capitalized in accordance with GAAP. Except as set forth in Schedule
      2.1(k),
      neither
      the Company nor any subsidiary is in default with respect to any
      Indebtedness.

     

    (l)  Title
      to Assets.
      Each of
      the Company and the subsidiaries has good and marketable title to all of its
      real and personal property reflected in the Form 10-KSB, the Form 10-QSB and
      the
      Form 8-K free and clear of any mortgages, pledges, charges, liens, security
      interests or other encumbrances, all properties and assets (i) purportedly
      owned
      or used by them as reflected in the Form 10-KSB, Form 10-QSBs, and the Form
      8-K
      or (ii) necessary for the conduct of their business as currently conducted
      except for those disclosed in the Form 10-KSB, Form 10-QSBs and the Form 8-K.
      All leases of the Company and each of its subsidiaries are valid and subsisting
      and in full force and effect.

     

    (m)  Actions
      Pending.
      There
      is no action, suit, claim, investigation, arbitration, alternate dispute
      resolution proceeding or any other proceeding pending or, to the knowledge
      of
      the Company, threatened against the Company or any subsidiary which questions
      the validity of this Agreement or any of the other Transaction Documents or
      the
      transactions contemplated hereby or thereby or any action taken or to be taken
      pursuant hereto or thereto. There is no action, suit, claim, investigation,
      arbitration, alternate dispute resolution proceeding or any other proceeding
      pending or, to the knowledge of the Company, threatened, against or involving
      the Company, any subsidiary or any of their respective properties or assets.
      There are no outstanding orders, judgments, injunctions, awards or decrees
      of
      any court, arbitrator or governmental or regulatory body against the Company
      or
      any subsidiary or any executive officers or directors of the Company or
      subsidiary in their capacities as such.

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

    (n)  Compliance
      with Law.
      The
      business of the Company and the subsidiaries has been and is presently being
      conducted in material compliance with all applicable federal, state and local
      governmental laws, rules, regulations and ordinances. The Company and each
      of
      its subsidiaries have all franchises, permits, licenses, consents and other
      governmental or regulatory authorizations and approvals necessary for the
      conduct of its business in all material respects as now being conducted by
      it
      unless the failure to possess such franchises, permits, licenses, consents
      and
      other governmental or regulatory authorizations and approvals, individually
      or
      in the aggregate, could not reasonably be expected to have a Material Adverse
      Effect.

     

    (o)  Taxes.
      The
      Company and each of the subsidiaries has accurately prepared and filed all
      federal, state and other tax returns required by law to be filed by it, has
      paid
      or made provisions for the payment of all taxes shown to be due and all
      additional assessments, and adequate provisions have been and are reflected
      in
      the financial statements of the Company and the subsidiaries for all current
      taxes and other charges to which the Company or any subsidiary is subject and
      which are not currently due and payable. None of the federal income tax returns
      of the Company or any subsidiary have been audited by the Internal Revenue
      Service. The Company has no knowledge of any additional assessments, adjustments
      or contingent tax liability (whether federal or state) of any nature whatsoever,
      whether pending or threatened against the Company or any subsidiary for any
      period, nor of any basis for any such assessment, adjustment or
      contingency.

     

    (p)  Certain
      Fees.
      Except
      as set forth on Schedule
      2.1(p)
      hereto,
      no brokers, finders or financial advisory fees or commissions will be payable
      by
      the Company or any subsidiary or any Purchaser with respect to the transactions
      contemplated by this Agreement and the other Transaction Documents.

     

    (q)  Operation
      of Business.
      The
      Company and each of the subsidiaries owns or possesses all patents, trademarks,
      domain names (whether or not registered) and any patentable improvements or
      copyrightable derivative works thereof, websites and intellectual property
      rights relating thereto, service marks, trade names, copyrights, licenses and
      authorizations, and all rights with respect to the foregoing, which are
      necessary for the conduct of its business as now conducted without any conflict
      with the rights of others, except where the failure to so own or possess would
      not have a Material Adverse Effect.

     

    (r)  Books
      and Record Internal Accounting Controls.
      Except
      as otherwise disclosed in the Form 10-KSB, the Form 10-QSB, or the Form 8-K,
      the
      books and records of the Company and its subsidiaries accurately reflect in
      all
      material respects the information relating to the business of the Company and
      the subsidiaries, the location and collection of their assets, and the nature
      of
      all transactions giving rise to the obligations or accounts receivable of the
      Company or any subsidiary. 

     

    (s)  Material
      Agreements.
      Neither
      the Company nor any subsidiary is a party to any written or oral contract,
      instrument, agreement, commitment, obligation, plan or arrangement, a copy
      of
      which would be required to be filed with the Commission as an exhibit to a
      registration statement on Form S-1 (collectively, the “Material
      Agreements”)
      if the
      Company or any subsidiary were registering securities under the Securities
      Act.
      The Company and each of its subsidiaries has in all material respects performed
      all the obligations required to be performed by them to date under the foregoing
      agreements, have received no notice of default and are not in default under
      any
      Material Agreement now in effect the result of which would cause a Material
      Adverse Effect. Except as restricted under applicable laws and regulations,
      the
      incorporation documents, certificate of designations or the Transaction
      Documents, no written or oral contract, instrument, agreement, commitment,
      obligation, plan or arrangement of the Company or of any subsidiary limits
      or
      shall limit the payment of dividends on the Company’s Preferred Shares, other
      preferred stock, if any, or its Common Stock.

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

     

    (t)  Transactions
      with Affiliates.
      Except
      as set forth in the Commission Documents, the Transaction Documents or the
      Entrustment Agreements(as defined in Section 2.1(dd)(i) below), there are no
      loans, leases, agreements, contracts, royalty agreements, management contracts
      or arrangements or other continuing transactions between (a) the Company or
      any
      subsidiary on the one hand, and (b) on the other hand, any officer, employee,
      consultant or director of the Company, or any of its subsidiaries, or any person
      owning any capital stock of the Company or any subsidiary or any member of
      the
      immediate family of such officer, employee, consultant, director or stockholder
      or any corporation or other entity controlled by such officer, employee,
      consultant, director or stockholder, or a member of the immediate family of
      such
      officer, employee, consultant, director or stockholder.

     

    (u)  Securities
      Act of 1933.
      Assuming the accuracy of the representations of the Purchasers set forth in
      Section 2.2 (d)-(h) hereof, the Company has complied and will comply with all
      applicable federal and state securities laws in connection with the offer,
      issuance and sale of the Shares and the Warrants hereunder. Neither the Company
      nor anyone acting on its behalf, directly or indirectly, has or will sell,
      offer
      to sell or solicit offers to buy any of the Units, the Shares, the Warrants
      or
      similar securities to, or solicit offers with respect thereto from, or enter
      into any preliminary conversations or negotiations relating thereto with, any
      person, or has taken or will take any action so as to bring the issuance and
      sale of any of the Units, the Shares and the Warrants in violation of the
      registration provisions of the Securities Act and applicable state securities
      laws, and neither the Company nor any of its affiliates, nor any person acting
      on its or their behalf, has engaged in any form of general solicitation or
      general advertising (within the meaning of Regulation D under the Securities
      Act) in connection with the offer or sale of any of the Units, the Shares and
      the Warrants.

     

    (v)  Governmental
      Approvals.
      Except
      for the filing of any notice prior or subsequent to the Closing Date that may
      be
      required under applicable state and/or Federal securities laws (which if
      required, shall be filed on a timely basis), including the filing of a Form
      D
      and a registration statement or statements pursuant to the Registration Rights
      Agreement, and the filing of the Series A Certificate of Designation with the
      Secretary of State for the State of Delaware, no authorization, consent,
      approval, license, exemption of, filing or registration with any court or
      governmental department, commission, board, bureau, agency or instrumentality,
      domestic or foreign, is or will be necessary for, or in connection with, the
      execution or delivery of the Units, the Preferred Shares and the Warrants,
      or
      for the performance by the Company of its obligations under the Transaction
      Documents.

     

    (w)  Absence
      of Certain Developments.
      Since
      December 31, 2007, neither the Company nor any subsidiary has:

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

     

    (i)  issued
      any stock, bonds or other corporate securities or any rights, options or
      warrants with respect thereto;

     

    (ii)  borrowed
      any amount or incurred or become subject to any liabilities (absolute or
      contingent) except current liabilities incurred in the ordinary course of
      business which are comparable in nature and amount to the current liabilities
      incurred in the ordinary course of business during the comparable portion of
      its
      prior fiscal year, as adjusted to reflect the current nature and volume of
      the
      Company’s or such subsidiary’s business;

     

    (iii)  discharged
      or satisfied any lien or encumbrance or paid any obligation or liability
      (absolute or contingent), other than current liabilities paid in the ordinary
      course of business;

     

    (iv)  declared
      or made any payment or distribution of cash or other property to stockholders
      with respect to its stock, or purchased or redeemed, or made any agreements
      so
      to purchase or redeem, any shares of its capital stock;

     

    (v)  sold,
      assigned or transferred any other tangible assets, or canceled any debts or
      claims, except in the ordinary course of business;

     

    (vi)  sold,
      assigned or transferred any patent rights, trademarks, trade names, copyrights,
      trade secrets or other intangible assets or intellectual property rights, or
      disclosed any proprietary confidential information to any person except to
      customers in the ordinary course of business or to the Purchasers or their
      representatives;

     

    (vii)  suffered
      any substantial losses or waived any rights of material value, whether or not
      in
      the ordinary course of business, or suffered the loss of any material amount
      of
      prospective business;

     

    (viii)  made
      any
      changes in employee compensation except in the ordinary course of business
      and
      consistent with past practices;

     

    (ix)  made
      capital expenditures or commitments therefor that aggregate in excess of
      $50,000;

     

    (x)  entered
      into any other transaction other than in the ordinary course of business, or
      entered into any other material transaction, whether or not in the ordinary
      course of business;

     

    (xi)  made
      charitable contributions or pledges in excess of $10,000;

     

    (xii)  suffered
      any material damage, destruction or casualty loss, whether or not covered by
      insurance;

     

    (xiii)  experienced
      any material problems with labor or management in connection with the terms
      and
      conditions of their employment;

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

     

    (xiv)  effected
      any two or more events of the foregoing kind which in the aggregate would be
      material to the Company or its subsidiaries; or

     

    (xv)  entered
      into an agreement, written or otherwise, to take any of the foregoing
      actions.

     

    (x)  Public
      Utility Holding Company Act and Investment Company Act Status.
      The
      Company is not a “holding company” or a “public utility company” as such terms
      are defined in the Public Utility Holding Company Act of 1935, as amended.
      The
      Company is not, and as a result of and immediately upon the Closing will not
      be,
      an “investment company” or a company “controlled” by an “investment company,”
within the meaning of the Investment Company Act of 1940, as
      amended.

     

    (y)  ERISA.
      No
      liability to the Pension Benefit Guaranty Corporation has been incurred with
      respect to any Plan (as defined below) by the Company or any of its subsidiaries
      which is or would be materially adverse to the Company and its subsidiaries.
      The
      execution and delivery of this Agreement and the other Transaction Documents
      and
      the issuance and sale of the Units, the Preferred Shares and the Warrants will
      not involve any transaction which is subject to the prohibitions of Section
      406
      of ERISA or in connection with which a tax could be imposed pursuant to Section
      4975 of the Internal Revenue Code of 1986, as amended, provided, that, if any
      of
      the Purchasers, or any person or entity that owns a beneficial interest in
      any
      of the Purchasers, is an “employee pension benefit plan” (within the meaning of
      Section 3(2) of ERISA) with respect to which the Company is a “party in
      interest” (within the meaning of Section 3(14) of ERISA), the requirements of
      Sections 407(d)(5) and 408(e) of ERISA, if applicable, are met. As used in
      this
      Section 2.1(ac), the term “Plan”
shall
      mean an “employee pension benefit plan” (as defined in Section 3 of ERISA) which
      is or has been established or maintained, or to which contributions are or
      have
      been made, by the Company or any subsidiary or by any trade or business, whether
      or not incorporated, which, together with the Company or any subsidiary, is
      under common control, as described in Section 414(b) or (c) of the
      Code.

     

    (z)  Dilutive
      Effect.
      The
      Company understands and acknowledges that it has an obligation to issue
      Conversion Shares upon conversion of the Preferred Shares in accordance with
      this Agreement and the Series A Certificate of Designation and to issue the
      Warrant Shares upon the exercise of the Warrants in accordance with this
      Agreement and the Warrants regardless of the dilutive effect that such issuance
      may have on the ownership interest of other stockholders of the
      Company.

     

    (aa)  No
      Integrated Offering.
      Neither
      the Company, nor any of its affiliates, nor any person acting on its or their
      behalf, has directly or indirectly made any offers or sales of any security
      or
      solicited any offers to buy any security under circumstances that would cause
      the offering of the Shares pursuant to this Agreement to be integrated with
      prior offerings by the Company for purposes of the Securities Act which would
      prevent the Company from selling the Shares pursuant to Rule 506 under the
      Securities Act, or any applicable exchange-related stockholder approval
      provisions, nor will the Company or any of its affiliates or subsidiaries take
      any action or steps that would cause the offering of the Shares to be integrated
      with other offerings. The Company does not have any registration statement
      pending before the Commission or currently under the Commission’s review and
      since January 1, 2007, except as contemplated under the Transaction Documents,
      the Company has not offered or sold any of its equity securities or debt
      securities convertible into shares of Common Stock.

     

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

     

    (bb)  Independent
      Nature of Purchasers.
      The
      Company acknowledges that the obligations of each Purchaser under the
      Transaction Documents are several and not joint with the obligations of any
      other Purchaser, and no Purchaser shall be responsible in any way for the
      performance of the obligations of any other Purchaser under the Transaction
      Documents. The Company acknowledges that the decision of each Purchaser to
      purchase securities pursuant to this Agreement has been made by such Purchaser
      independently of any other purchase and independently of any information,
      materials, statements or opinions as to the business, affairs, operations,
      assets, properties, liabilities, results of operations, condition (financial
      or
      otherwise) or prospects of the Company or of its Subsidiaries which may have
      made or given by any other Purchaser or by any agent or employee of any other
      Purchaser, and no Purchaser or any of its agents or employees shall have any
      liability to any Purchaser (or any other person) relating to or arising from
      any
      such information, materials, statements or opinions. The Company acknowledges
      that nothing contained herein, or in any Transaction Document, and no action
      taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute
      the Purchasers as a partnership, an association, a joint venture or any other
      kind of entity, or create a presumption that the Purchasers are in any way
      acting in concert or as a group with respect to such obligations or the
      transactions contemplated by the Transaction Documents. The Company acknowledges
      that each Purchaser shall be entitled to independently protect and enforce
      its
      rights, including without limitation, the rights arising out of this Agreement
      or out of the other Transaction Documents, and it shall not be necessary for
      any
      other Purchaser to be joined as an additional party in any proceeding for such
      purpose. The Company acknowledges that for reasons of administrative convenience
      only, the Transaction Documents have been reviewed by counsel for one of the
      Purchasers and such counsel does not represent all of the Purchasers but only
      such Purchaser and the other Purchasers have retained their own individual
      counsel with respect to the transactions contemplated hereby. The Company
      acknowledges that it has elected to provide all Purchasers with the same terms
      and Transaction Documents for the convenience of the Company and not because
      it
      was required or requested to do so by the Purchasers.

     

    (cc)  Transfer
      Agent.
      The
      name, address, telephone number, fax number, contact person and email address
      of
      the Company’s current transfer agent is set forth on Schedule
      2.1(cc)
      hereto.

     

    (dd)  Subject
      to the consummation of the Share Exchange Transaction, the Company represents
      on
      behalf of WFOE, and, upon consummation of the Share Exchange
      Transaction:

     

    (i)  that
      WFOE
      has the legal right, power and authority (corporate and other) to enter into
      and
      perform its obligations under each of agreements with Shanghai Atrip Medical
      Technology Co., Ltd., a PRC company (“SMT”),
      as
      set forth on Schedule
      2.1(dd)
      (collectively, the “Entrustment
      Agreements”)
      to
      which it is a party and has taken all necessary corporate action to authorize
      the execution, delivery and performance of, and has authorized, executed and
      delivered, each of the Entrustment Agreements to which it is a party; and each
      of the Entrustment Agreements to which WFOE is a party constitutes a valid
      and
      legally binding obligation of WFOE, enforceable in accordance with its terms,
      subject, as to enforceability, to bankruptcy, insolvency, fraudulent transfer,
      reorganization, moratorium and similar laws of general applicability relating
      to
      or affecting creditors’ rights and to general equity principles.

     

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

     

    (ii)  that
      WFOE
      does not own or lease properties or conduct any business outside of the PRC
      and
      that WFOE does not need to be duly qualified as a foreign corporation for the
      transaction of business under the laws of any jurisdiction in which it is not
      now so qualified.

     

    (iii)  that
      the
      execution and delivery by WFOE of, and the performance by WFOE of its
      obligations under, each of the Entrustment Agreements to which it is a party
      and
      the consummation by WFOE of the transactions contemplated therein will not:
      (A)
      conflict with or result in a breach or violation of any of the terms or
      provisions of, or constitute a default under, any indenture, mortgage, deed
      of
      trust, loan agreement or other agreement or instrument to which WFOE is a party
      or by which WFOE is bound or to which any of the properties or assets of WFOE
      is
      subject; (B) result in any violation of the provisions of the articles of
      association or business license of WFOE; and (C) will not result in any
      violation of any laws, regulations, rules, orders, decrees, guidelines or
      notices of the PRC, except that, with respect to (A) and (C), such conflict,
      breach or violation would not reasonably be expected to have a Material Adverse
      Effect.

     

    (iv)  
      that
      each of the Entrustment Agreements is in proper and enforceable legal form
      under
      the laws of the PRC and to ensure the legality, validity, enforceability or
      admissibility in evidence of each of the Entrustment Agreements in the PRC,
      it
      is not necessary that any such document be filed or recorded with any court
      or
      other authority in the PRC or that any stamp or similar tax be paid on or in
      respect of any of the Restructuring Agreements, except as set forth on
Schedule
      2.1(dd)(iv).that
      all
      material consents, approvals, authorizations or licenses requisite under PRC
      law
      for the due and proper establishment and operation of WFOE have been duly
      obtained from the relevant PRC governmental authorities and are in full force
      and effect. Each of the Entrustment Agreements has been duly executed by each
      party thereto and, when delivered in accordance with the terms hereof, will
      constitute the valid and binding obligation of such Person, enforceable against
      each in accordance with its terms, except as such enforceability may be limited
      by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
      or
      similar laws relating to, or affecting generally the enforcement of, creditors’
rights and remedies or by other equitable principles of general application.
      The
      Entrustment Agreements fully and legally transfer from SMT to WFOE all of the
      right to transact in and with, sell, license, encumber, grants right in and
      to,
      dispose of, and otherwise deal in and with any and all of the assets (including,
      without limitation, the goodwill, intellectual property rights, profits,
      tangible and intangible assets, rights, claims, rebates, refunds and
      properties), and liabilities of SMT. The Entrustment Agreements comply in all
      material respects with the laws and regulations of the PRC.

     

    (v)  
      All
      filings and registrations with the PRC governmental authorities required in
      respect of WFOE and its capital structure and operations including, without
      limitation, the registration with the Ministry of Commerce, the China Securities
      Regulatory Commission, the State Administration of Industry and Commerce, the
      State Administration for Foreign Exchange, tax bureau and customs authorities
      have been duly completed in accordance with the relevant PRC rules and
      regulations, except where, the failure to complete such filings and
      registrations does not, and would not, individually or in the aggregate, have
      a
      Material Adverse Effect.

     

    
      
        
        

      

      
        13

        
          

        

      

      
        
        

      

    

     

    (vi)  
      WFOE has
      complied with all relevant PRC laws and regulations regarding the contribution
      and payment of its registered share capital, the payment schedule of which
      has
      been approved by the relevant PRC governmental authorities. There are no
      outstanding rights of, or commitments made by the Company or any Subsidiary
      to
      sell any equity interest in WFOE.

    

    (vii)  
      WFOE is
      not in receipt of any letter or notice from any relevant PRC governmental or
      quasi-governmental authority notifying it of revocation of any licenses or
      qualifications issued to it or any subsidy granted to it by any PRC governmental
      authority for non-compliance with the terms thereof or with applicable PRC
      laws,
      or the need for compliance or remedial actions in respect of the activities
      carried out by WFOE, except such revocation does not, and would not,
      individually or in the aggregate, have a Material Adverse Effect.

    

    (viii)  
      WFOE has
      conducted its business activities within the permitted scope of business or
      has
      otherwise operated its business in compliance with all relevant legal
      requirements and with all requisite licenses and approvals granted by competent
      PRC governmental authorities other than such non-compliance that do not, and
      would not, individually or in the aggregate, have a Material Adverse Effect.
      As
      to licenses, approvals and government grants and concessions requisite or
      material for the conduct of any part of WFOE’s business which is subject to
      periodic renewal, the Company has no knowledge of any grounds on which such
      requisite renewals will not be granted by the relevant PRC governmental
      authorities.

    

    With
      regard to employment and staff or labor, WFOE has complied with all applicable
      PRC laws and regulations in all material respects, including without limitation,
      laws and regulations pertaining to welfare funds, social benefits, medical
      benefits, insurance, retirement benefits, pensions or the like, other than
      such
      non-compliance that do not, and would not, individually or in the aggregate,
      have a Material Adverse Effect.

     

    Section
      2.2  Representations
      and Warranties of the Purchasers.
      Each
      Purchaser hereby makes the following representations and warranties to the
      Company as of the date hereof and Closing Date, with respect solely to itself
      and not with respect to any other Purchaser:

     

    (a)  Organization
      and Good Standing of the Purchasers.
      If the
      Purchaser is an entity, such Purchaser is a corporation, partnership or limited
      liability company duly incorporated or organized, validly existing and in good
      standing under the laws of the jurisdiction of its incorporation or
      organization.

     

    (b)  Authorization
      and Power.
      Each
      Purchaser has the requisite power and authority to enter into and perform this
      Agreement and each of the other Transaction Documents to which such Purchaser
      is
      a party and to purchase the Preferred Shares and Warrants being sold to it
      hereunder. The execution, delivery and performance of this Agreement and each
      of
      the other Transaction Documents to which such Purchaser is a party by such
      Purchaser and the consummation by it of the transactions contemplated hereby
      and
      thereby have been duly authorized by all necessary corporate or partnership
      action, and no further consent or authorization of such Purchaser or its Board
      of Directors, stockholders, or partners, as the case may be, is required. This
      Agreement and each of the other Transaction Documents to which such Purchaser
      is
      a party has been duly authorized, executed and delivered by such Purchaser
      and
      constitutes, or shall constitute when executed and delivered, a valid and
      binding obligation of such Purchaser enforceable against such Purchaser in
      accordance with the terms thereof.

     

    
      
        
        

      

      
        14

        
          

        

      

      
        
        

      

    

     

    (c)  No
      Conflicts.
      The
      execution, delivery and performance of this Agreement and each of the other
      Transaction Documents to which such Purchaser is a party and the consummation
      by
      such Purchaser of the transactions contemplated hereby and thereby or relating
      hereto do not and will not (i) result in a violation of such Purchaser’s charter
      documents, bylaws, operating agreement, partnership agreement or other
      organizational documents or (ii) conflict with, or constitute a default (or
      an
      event which with notice or lapse of time or both would become a default) under,
      or give to others any rights of termination, amendment, acceleration or
      cancellation of any agreement, indenture or instrument or obligation to which
      such Purchaser is a party or by which its properties or assets are bound, or
      result in a violation of any law, rule, or regulation, or any order, judgment
      or
      decree of any court or governmental agency applicable to such Purchaser or
      its
      properties (except for such conflicts, defaults and violations as would not,
      individually or in the aggregate, have a material adverse effect on such
      Purchaser). Such Purchaser is not required to obtain any consent, authorization
      or order of, or make any filing or registration with, any court or governmental
      agency in order for it to execute, deliver or perform any of its obligations
      under this Agreement or any other Transaction Document to which such Purchaser
      is a party or to purchase the Preferred Shares or acquire the Warrants in
      accordance with the terms hereof, provided, that for purposes of the
      representation made in this sentence, such Purchaser is assuming and relying
      upon the accuracy of the relevant representations and agreements of the Company
      herein.

     

    (d)  Acquisition
      for Investment.
      Each
      Purchaser is acquiring the Units, and the underlying Preferred Shares and the
      Warrants solely for its own account for the purpose of investment and not with
      a
      view to or for sale in connection with distribution. Each Purchaser does not
      have a present intention to sell the Preferred Shares or the Warrants, nor
      a
      present arrangement (whether or not legally binding) or intention to effect
      any
      distribution of the Shares or the Warrants to or through any person or entity;
      provided,
      however,
      that by
      making the representations herein and subject to Section 2.2(h) below, such
      Purchaser does not agree to hold the Shares or the Warrants for any minimum
      or
      other specific term and reserves the right to dispose of the Shares or the
      Warrants at any time in accordance with Federal and state securities laws
      applicable to such disposition. Each Purchaser acknowledges that it is able
      to
      bear the financial risks associated with an investment in the Shares and the
      Warrants and that it has been given full access to such records of the Company
      and the subsidiaries and to the officers of the Company and the subsidiaries
      and
      received such information as it has deemed necessary or appropriate to conduct
      its due diligence investigation and has sufficient knowledge and experience
      in
      investing in companies similar to the Company in terms of the Company’s stage of
      development so as to be able to evaluate the risks and merits of its investment
      in the Company. Each Purchaser further acknowledges that such Purchaser
      understands the risks of investing in companies domiciled and/or which operate
      primarily in the People’s Republic of China and that the purchase of the Shares
      and Warrants involves substantial risks.

     

    
      
        
        

      

      
        15

        
          

        

      

      
        
        

      

    

     

    (e)  Status
      of Purchasers.
      Each
      Purchaser is an “accredited investor” as defined in Regulation D promulgated
      under the Securities Act. Such Purchaser is not required to be registered as
      a
      broker-dealer under Section 15 of the Exchange Act and such Purchaser is not
      a
      broker-dealer, nor an affiliate of a broker-dealer.

     

    (f)  Opportunities
      for Additional Information.
      Each
      Purchaser acknowledges that such Purchaser has had the opportunity to ask
      questions of and receive answers from, or obtain additional information from,
      the executive officers of the Company concerning the financial and other affairs
      of the Company. In making the decision to invest in the Company and its
      business, each Purchaser hereby acknowledges that such Purchaser has relied
      solely upon the Kamick Financial Statements, the Draft Form 8-K (defined in
      Section 4.2(v) hereto) and other written information provided to such Purchaser
      by the Company and Kamick.

     

    (g)  No
      General Solicitation.
      Each
      Purchaser acknowledges that the Units were not offered to such Purchaser by
      means of any form of general or public solicitation or general advertising,
      or
      publicly disseminated advertisements or sales literature, including (i) any
      advertisement, article, notice or other communication published in any
      newspaper, magazine, or similar media, or broadcast over television or radio,
      or
      (ii) any seminar or meeting to which such Purchaser was invited by any of the
      foregoing means of communications.

     

    (h)  Rule
      144.
      Such
      Purchaser understands that the Shares must be held indefinitely unless such
      Shares are registered under the Securities Act or an exemption from registration
      is available. Such Purchaser acknowledges that such Purchaser is familiar with
      Rule 144 of the rules and regulations of the Commission, as amended, promulgated
      pursuant to the Securities Act (“Rule
      144”),
      and
      that such person has been advised that Rule 144 permits resales only under
      certain circumstances. Such Purchaser understands that to the extent that Rule
      144 is not available, such Purchaser will be unable to sell any Shares without
      either registration under the Securities Act or the existence of another
      exemption from such registration requirement.

     

    (i)  General.
      Such
      Purchaser understands that the Shares are being offered and sold in reliance
      on
      a transactional exemption from the registration requirement of Federal and
      state
      securities laws and the Company is relying upon the truth and accuracy of the
      representations, warranties, agreements, acknowledgments and understandings
      of
      such Purchaser set forth herein in order to determine the applicability of
      such
      exemptions and the suitability of such Purchaser to acquire the
      Shares.

     

    (j)  Independent
      Investment.
      Except
      as may be disclosed in any filings with the Commission by the Purchasers under
      Section 13 and/or Section 16 of the Exchange Act, no Purchaser has agreed to
      act
      with any other Purchaser for the purpose of acquiring, holding, voting or
      disposing of the Shares purchased hereunder for purposes of Section 13(d) under
      the Exchange Act, and each Purchaser is acting independently with respect to
      its
      investment in the Shares.

     

    (k)  Trading
      Activities.
      Such
      Investor has not directly or indirectly, nor has any Person acting on behalf
      of
      or pursuant to any understanding with such Investor, engaged in any transactions
      in the securities of the Company (including, without limitations, any short
      sales involving the Company’s securities) since the earlier to occur of (i) the
      time that such Investor was first contacted by the Company regarding an
      investment in the Company and (ii) the 30th
      day
      prior to the date of this Agreement. Such Investor covenants that neither it
      nor
      any Person acting on its behalf or pursuant to any understanding with it will
      engage in any transactions in the securities of the Company (including Short
      Sales) prior to the time that the transactions contemplated by this Agreement
      are publicly disclosed.

     

    
      
        
        

      

      
        16

        
          

        

      

      
        
        

      

    

    

    (l)  Brokers.
      Other
      than to Capital Investment Services, Inc. (“CIS”), each Purchaser has no
      knowledge of any brokerage or finder’s fees or commissions that are or will be
      payable by the Company or any Subsidiary to any broker, financial advisor or
      consultant, finder, placement agent, investment banker, bank or other person
      or
      entity with respect to the transactions contemplated by this
      Agreement

     

    ARTICLE
      III

     

    Covenants

     

    The
      Company covenants with each of the Purchasers as follows, which covenants are
      for the benefit of the Purchasers and their permitted assignees (as defined
      herein).

     

    Section
      3.1  Securities
      Compliance.
      The
      Company shall notify the Commission in accordance with their rules and
      regulations, of the transactions contemplated by any of the Transaction
      Documents, including filing a Form D with respect to the Units, the Preferred
      Shares, Warrants, Conversion Shares and Warrant Shares as required under
      Regulation D and applicable “blue sky” laws, and shall take all other necessary
      action and proceedings as may be required and permitted by applicable law,
      rule
      and regulation, for the legal and valid issuance of the Units, the Preferred
      Shares, the Warrants, the Conversion Shares and the Warrant Shares to the
      Purchasers or subsequent holders.

     

    Section
      3.2  Registration
      and Listing.
      The
      Company shall (a) comply in all respects with its reporting and filing
      obligations under the Exchange Act, (b) comply with all requirements related
      to
      any registration statement filed pursuant to this Agreement or the Registration
      Rights Agreement, and (c) not take any action or file any document (whether
      or
      not permitted by the Securities Act or the rules promulgated thereunder) to
      terminate or suspend such registration or to terminate or suspend its reporting
      and filing obligations under the Exchange Act or Securities Act except as
      permitted under the Transaction Documents. The Company will take all action
      necessary to continue the quotation or listing of its Common Stock on the OTC
      Bulletin Board or other exchange or market on which the Common Stock is trading
      or may be traded in the future. Subject to the terms of the Transaction
      Documents, the Company further covenants that it will take such further action
      as the Purchasers may reasonably request, all to the extent required from time
      to time to enable the Purchasers to sell the Shares without registration under
      the Securities Act within the limitation of the exemptions provided by Rule
      144
      promulgated under the Securities Act, as amended. Upon the request of the
      Purchasers, the Company shall deliver to the Purchasers a written certification
      of a duly authorized officer as to whether it has complied with such
      requirements.

     

    
      
        
        

      

      
        17

        
          

        

      

      
        
        

      

    

     

    Section
      3.3  Compliance
      with Laws.
      The
      Company shall comply, and cause each subsidiary to comply in all material
      respects, with all applicable laws, rules, regulations and orders.

     

    Section
      3.4  Keeping
      of Records and Books of Account.
      The
      Company shall keep and cause each subsidiary to keep adequate records and books
      of account, in which complete entries will be made in accordance with GAAP
      consistently applied, reflecting all financial transactions of the Company
      and
      its subsidiaries, and in which, for each fiscal year, all proper reserves for
      depreciation, depletion, obsolescence, amortization, taxes, bad debts and other
      purposes in connection with its business shall be made.

     

    Section
      3.5  Reporting
      Requirements.
      If the
      Commission ceases making periodic reports filed under the Exchange Act available
      via the Internet, then at a Purchaser’s request the Company shall furnish the
      following to such Purchaser so long as such Purchaser shall beneficially own
      any
      Shares:

     

    (a)  Quarterly
      Reports filed with the Commission on Form 10-QSB as soon as practical after
      the
      document is filed with the Commission, and in any event within five (5) days
      after the document is filed with the Commission;

     

    (b)  Annual
      Reports filed with the Commission on Form 10-KSB as soon as practical after
      the
      document is filed with the Commission, and in any event within five (5) days
      after the document is filed with the Commission; and

     

    (c)  Copies
      of
      all notices and information, including without limitation notices and proxy
      statements in connection with any meetings, that are provided to holders of
      shares of Common Stock, contemporaneously with the delivery of such notices
      or
      information to such holders of Common Stock.

     

    Section
      3.6  Other
      Agreements.
      The
      Company shall not enter into any agreement in which the terms of such agreement
      would restrict or impair the right or ability to perform of the Company or
      any
      subsidiary under any Transaction Document. The Company shall take all necessary
      steps to have Board of Directors composed of a majority of independent directors
      within 120 days of the Closing Date.

     

    Section
      3.7  Distributions.
      So long
      as any Preferred Shares remain outstanding, the Company agrees that it shall
      not
      (i) declare or pay any dividends or make any distributions to any holder(s)
      of
      Common Stock unless such dividends or distributions are also simultaneously
      paid
      or made to the holders of the Preferred Shares on an as-converted basis or
      (ii)
      purchase or otherwise acquire for value, directly or indirectly, any Common
      Stock or other equity security of the Company.

     

    Section
      3.8  Reservation
      of Shares.
      So long
      as any of the Preferred Shares or Warrants remain outstanding, the Company
      shall
      take all action necessary to at all times have authorized, and reserved for
      the
      purpose of issuance, no less than one hundred fifty percent (150%) of the
      aggregate number of shares of Common Stock needed to provide for the issuance
      of
      the Conversion Shares and the Warrant Shares.

     

    
      
        
        

      

      
        18

        
          

        

      

      
        
        

      

    

     

    Section
      3.9  Transfer
      Agent Instructions.
      The
      Company shall issue irrevocable instructions to its transfer agent, and any
      subsequent transfer agent, to issue certificates, registered in the name of
      each
      Purchaser or its respective nominee(s), for the Conversion Shares and the
      Warrant Shares in such amounts as specified from time to time by each Purchaser
      to the Company upon conversion of the Preferred Shares or exercise of the
      Warrants in the form of Exhibit
      G
      attached
      hereto (the “Irrevocable
      Transfer Agent Instructions”).
      Prior
      to registration of the Conversion Shares and the Warrant Shares under the
      Securities Act, all such certificates shall bear the restrictive legend
      specified in Section 5.1 of this Agreement. The Company warrants that no
      instruction other than the Irrevocable Transfer Agent Instructions referred
      to
      in this Section 3.9 will be given by the Company to its transfer agent and
      that
      the Shares shall otherwise be freely transferable on the books and records
      of
      the Company as and to the extent provided in this Agreement and the Registration
      Rights Agreement. If a Purchaser provides the Company with an opinion of
      counsel, in a generally acceptable form, to the effect that a public sale,
      assignment or transfer of the Shares may be made without registration under
      the
      Securities Act or the Purchaser provides the Company with reasonable assurances
      that such Shares can be sold pursuant to Rule 144 without any restriction as
      to
      the number of securities acquired as of a particular date that can then be
      immediately sold, the Company shall permit the transfer, and, in the case of
      the
      Conversion Shares and the Warrant Shares, promptly instruct its transfer agent
      to issue one or more certificates in such name and in such denominations as
      specified by such Purchaser and without any restrictive legend. The Company
      acknowledges that a breach by it of its obligations under this Section 3.9
      will
      cause irreparable harm to the Purchasers by vitiating the intent and purpose
      of
      the transaction contemplated hereby. Accordingly, the Company acknowledges
      that
      the remedy at law for a breach of its obligations under this Section 3.9 will
      be
      inadequate and agrees, in the event of a breach or threatened breach by the
      Company of the provisions of this Section 3.9, that the Purchasers shall be
      entitled, in addition to all other available remedies, to an order and/or
      injunction restraining any breach and requiring immediate issuance and transfer,
      without the necessity of showing economic loss and without any bond or other
      security being required.

     

    Section
      3.10  Disposition
      of Assets.
      So long
      as any Preferred Shares remain outstanding, neither the Company nor any
      Subsidiary shall sell, transfer or otherwise dispose of any of its properties,
      assets and rights including, without limitation, its software and intellectual
      property, to any person except for (i) sales to customers in the ordinary course
      of business (ii) sales or transfers between the Company and its Subsidiaries
      or
      between Subsidiaries of the Company, (iii) sales or transfers between the
      Company, any of its Subsidiaries or (iv) otherwise with the prior written
      consent of the holders of a majority of the Preferred Shares then
      outstanding.

     

    Section
      3.11  Reporting
      Status.
      So long
      as a Purchaser beneficially owns any of the Shares, the Company shall timely
      file all reports required to be filed with the Commission pursuant to the
      Exchange Act, and the Company shall not terminate its status as an issuer
      required to file reports under the Exchange Act even if the Exchange Act or
      the
      rules and regulations thereunder would permit such termination.

     

    Section
      3.12  Lock-Up
      Agreement.
      The
      persons listed on Schedule
      3.12
      attached
      hereto shall be subject to the terms and provisions of a lock-up agreement
      in
      substantially the form as Exhibit
      E
      hereto
      (the “Lock-Up
      Agreement”),
      which
      shall provide the manner in which such persons will sell, transfer or dispose
      of
      their shares of Common Stock.

     

    
      
        
        

      

      
        19

        
          

        

      

      
        
        

      

    

     

    Section
      3.13  Investor
      and Public Relations Escrow.
      The
      Company shall cause to be deposited pursuant to the terms of a General Escrow
      Agreement to be dated as of the Closing Date (the “General
      Escrow Agreement”),
      Three
      Hundred Thousand Dollars ($300,000) of the Purchase Price funded on the Closing
      Date in an escrow account to be used by the Company in connection with investor
      and public relations.

     

    Section
      3.14  
      Integration.
      The
      Company shall not, and shall use its best efforts to ensure that no Affiliate
      of
      the Company shall, sell, offer for sale or solicit offers to buy or otherwise
      negotiate in respect of any security (as defined in Section 2 of the Securities
      Act) that would be integrated with the offer or sale of the Shares and the
      Warrants in a manner that would require the registration under the Securities
      Act of the sale of the Shares and the Warrants to the Investors, or that would
      be integrated with the offer or sale of the Shares and the Warrants for purposes
      of the rules and regulations of any Trading Market in a manner that would
      require stockholder approval of the sale of the Shares and the Warrants to
      the
      Investors.

     

    Section
      3.15  Limitation on Issuance of Future Priced Securities.
      During the twelve months following the Closing Date, the Company shall not
      issue
      any “Future Priced Securities” as such term is described by NASD
      IM-4350-1.

     

    Section
      3.16  Additional
      Operating Covenants.
      Save
      as
      to the transactions contemplated under this Agreement and other Transaction
      Documents, including the Schedule on Use of Funds attached hereto as Exhibit
      J ,
      the Company, ABM, WFOE and SMT (the “Group
      Companies”)shall
      not:

    

    
      	 	
              (a)

            	
              
                acquire
                  or dispose of, or agree to acquire or dispose of, any material
                  asset, or
                  enter into or amend any agreement or incur any commitment to do
                  so, in
                  each case involving consideration, expenditure or liabilities in
                  excess of
                  US$7 million;.

              

            

    

    

    
      	 	
              (b)

            	
              acquire
                or agree to acquire any share, shares or other interest in any company,
                partnership or other venture;

            

    

    

    
      	 	
              (c)

            	
              incur
                any additional borrowings or incur any other indebtedness for borrowed
                money for
                five years after Closing,
                other than trade indebtedness incurred in the ordinary course of
                business,
                which would cause the Company’s borrowings
                to be more than twice as much as the sum of the earnings before income
                taxes, depreciation and amortization from recurring operations over
                the
                prior four quarters. 

            

    

    

    
      	 	
              (d)

            	
              other
                than in relation to the issue of the Conversion Shares or Warrant
                Shares,
                and other than with respect to the Company Stock Option Plan, create,
                allot or issue any share capital or loan capital of any Group Company
                or
                any option, warrant, or similar right to subscribe for the
                same;

            

    

     

    
      
        
        

      

      
        20

        
          

        

      

      
        
        

      

    

     

    
      	 	
              (e)

            	
              repay,
                redeem or repurchase or agree to repay, redeem or repurchase any
                share
                capital or loan capital of any Group Company;

            

    

    

    
      	
            	(f)	
              subdivide
                outstanding share capital into a larger number of shares, combine
                (including by way of reverse stock split) outstanding share capital
                into a
                smaller number of shares, or issue by reclassification any share
                capital;

            

    

    

    
      	
            	(g)	
              subdivide
                outstanding share capital into a larger number of shares, combine
                (including by way of reverse stock split) outstanding share capital
                into a
                smaller number of shares, or issue by reclassification any share
                capital;

            

    

    

    
      	
            	(h)	
              effect
                any merger or consolidation of the any Group Company with or into
                another
                Person (other than a merger or consolidation between wholly-owned
                subsidiaries of the Company), effect any sale of all or substantially
                all
                of its assets in one or a series of related transactions, enter into
                or
                support any tender offer or exchange offer (whether by the Company
                or
                another Person) pursuant to which holders of share capital or other
                securities of any Group Company are permitted to tender or exchange
                their
                shares or securities for other securities, for cash or for property,
                or
                effect any reclassification of its share capital or any compulsory
                share
                exchange pursuant to which the share capital or any Group Company
                is
                effectively converted into or exchanged for other securities, cash
                or
                property;

            

    

     

    
      	 	
              (i)

            	
              enter
                into any guarantee, indemnity or other agreement to secure any obligation
                of a third party or create any Encumbrance over any of its assets
                or
                undertaking in any such case, save in the ordinary course of business
                and
                any approved borrowing or loan(s) which do not exceed US$7 million
                in the
                aggregate;

            

    

    

    
      	 	
              (j)

            	
              other
                than with respect to one or more other Group Companies, sell, transfer,
                license or grant any rights to the use or enjoyment of any Intellectual
                Property; 

            

    

    

    
      	 	
              (k)

            	
              enter
                into any transaction(s) aggregating in excess of $120,000 in 12 month
                period which any executive officer or director or their families
                had or
                will have a direct or indirect material interest, except those entered
                into at arm’s length in the usual and ordinary course of
                business;

            

    

    

    
      	 	
              (l)

            	
              commencing
                or acquiring any new line of business which does not fall within
                the
                Business or engaging in any other business activities beyond the
                scope of
                the Business;

            

    

    

    
      	 	
              (m)

            	
              make
                or agree to make or extend any loan or advance to any person, firm,
                body
                corporate or other business other than in the normal course of business
                and on an arms’ length basis; 

            

    

     

    
      
        
        

      

      
        21

        
          

        

      

      
        
        

      

       

    

    
      	 	
              (n)

            	
              amend
                its memorandum or articles of association or other respective governing
                or
                formational documents.

            

    

     

    Section
      3.17 Subsequent
      Financings 

     

    (a)
      Until
      December 31, 2009, the Company covenants and agrees to promptly notify (in
      no
      event later than five (5) days after making or receiving an applicable offer)
      in
      writing (a “Rights
      Notice”)
      each
      holder of Preferred Shares (each, a “Preferred
      Stockholder”
and
      collectively the “Preferred
      Stockholders”)
      of the
      terms and conditions of any proposed offer or sale to, or exchange with (or
      other type of distribution to) any third party, of Common Stock, any debt or
      equity securities convertible, exercisable or exchangeable into Common Stock
      or
      any debt securities (a “Subsequent
      Financing”);
      provided,
      however,
      prior
      to delivering to each Preferred Stockholder a Rights Notice, the Company shall
      first deliver to each Preferred Stockholder a written notice of its intention
      to
      effect a Subsequent Financing (“Pre-Notice”)
      within
      three (3) Trading Days of receiving an applicable offer, which Pre-Notice shall
      ask such Preferred Stockholder if it wants to review the details of such
      financing. Upon the request of a Preferred Stockholder, and only upon a request
      by such Preferred Stockholder within three (3) Trading Days of receipt of a
      Pre-Notice, the Company shall promptly, but no later than two (2) Trading Days
      after such request, deliver a Rights Notice to such Preferred Stockholder.
      The
      Rights Notice shall describe, in reasonable detail, the proposed Subsequent
      Financing, the names and investment amounts of all investors participating
      in
      the Subsequent Financing (if known), the proposed closing date of the Subsequent
      Financing, which shall be no earlier than ten (10) Trading Days from the date
      of
      the Rights Notice, and all of the terms and conditions thereof and proposed
      definitive documentation to be entered into in connection therewith. The Rights
      Notice shall provide each Preferred Stockholder an option (the “Rights
      Option”)
      during
      the ten (10) Trading Days following delivery of the Rights Notice (the
“Option
      Period”)
      to
      inform the Company whether such Preferred Stockholder will purchase up to its
      pro rata portion of all or a portion of the securities being offered in such
      Subsequent Financing on the same, absolute terms and conditions as contemplated
      by such Subsequent Financing. If any Preferred Stockholder elects not to
      participate in such Subsequent Financing, the other Preferred Stockholders
      may
      participate on a pro-rata basis. For purposes of this Section, all references
      to
“pro rata” means, for any Preferred Stockholder electing to participate in such
      Subsequent Financing, the percentage obtained by dividing (x) the number of
      Preferred Shares held by such Preferred Stockholder at the Initial Closing
      plus
      the number of Preferred Shares purchased at any Additional Closing, by (y)
      the
      total number of all of the Preferred Shares issued hereunder. Delivery of any
      Rights Notice constitutes a representation and warranty by the Company that
      there are no other material terms and conditions, arrangements, agreements
      or
      otherwise except for those disclosed in the Rights Notice, to provide additional
      compensation to any party participating in any proposed Subsequent Financing,
      including, but not limited to, additional compensation based on changes in
      the
      Purchase Price or any type of reset or adjustment of a purchase or conversion
      price or to issue additional securities at any time after the closing date
      of a
      Subsequent Financing. If the Company does not receive notice of exercise of
      the
      Rights Option from the Preferred Stockholder within the Option Period, the
      Company shall have the right to close the Subsequent Financing on the scheduled
      closing date with a third party; provided,
      that
      all of the material terms and conditions of the closing are the same as those
      provided to the Preferred Stockholder in the Rights Notice. If the closing
      of
      the proposed Subsequent Financing does not occur that date, any closing of
      the
      contemplated Subsequent Financing or any other Subsequent Financing shall be
      subject to all of the provisions of this Section 3.17(a), including, without
      limitation, the delivery of a new Rights Notice. The provisions of this Section
      3.17(a) shall not apply to issuances of securities in a Permitted
      Financing.

     

    
      
        
        

      

      
        22

        
          

        

      

      
        
        

      

    

     

    (b)  For
      purposes of this Agreement, a Permitted Financing (as defined hereinafter)
      shall
      not be considered a Subsequent Financing. A “Permitted
      Financing”
shall
      mean (i) securities issued (other than for cash) in connection with a merger,
      acquisition, or consolidation, (ii) securities issued pursuant to the conversion
      or exercise of convertible or exercisable securities issued or outstanding
      on or
      prior to the date of this Agreement or issued pursuant to this Agreement or
      any
      of the other Transaction Documents (so long as the conversion or exercise price
      in such securities are not amended to lower such price and/or adversely affect
      the Purchasers), (iii) securities issued in connection with bona fide strategic
      license agreements or other partnering arrangements so long as such issuances
      are not for the purpose of raising capital, (iv) Common Stock issued or the
      issuance or grants of options to purchase Common Stock pursuant to the Company’s
      Stock Option Plan (as defined below), and (v) any warrants issued to the
      placement agent, financial advisors and their respective designees for the
      transactions contemplated by the Transaction Documents.

     

    (c)  Nothing
      herein shall prohibit the Company from establishing an employee stock option,
      restricted stock or other form of equity incentive plan “Stock
      Option Plan”) reserving
      a number of shares not to exceed ten percent (10%) in the aggregate of the
      total
      number of issued and outstanding shares of Common Stock, Conversion Shares
      issuable upon conversion of all outstanding Preferred Stock and shares of Common
      Stock issuable upon exercise of all outstanding warrants (but not including
      shares of Common Stock issued upon exercise of options issued pursuant to a
      Stock Option Plan), for employees, officers or directors of the Company;
      provided, however, that such Stock Option Plan or Plans must (i) be approved
      by
      the Board; (ii) require that the exercise or strike price be no less than the
      Warrant Exercise price, as adjusted; (iii) provide at a minimum a three(or
      whatever longer period is required by listing exchange) year vesting schedule;
      and (iv) provide that options or similar rights for no more than 35% of the
      total number of Shares that may be issued thereunder may be issued to any one
      person; and provided further that, so long as the Preferred Shares and shares
      of
      Common Stock issued upon conversion of Preferred Shares still held by the
      original holders or their affiliates (the “Holders”) equals at least 25% of the
      initial Preferred Shares issued by the Company (the “Minimum Holding”), the
      Company shall not, without first obtaining the approval (by vote or written
      consent, as provided by law) of the holders of at least seventy-five percent
      (75%) of the then outstanding Preferred Shares, voting as a separate
      class:

     

    (i)
       on
      or
      prior to April 15, 2008 (the “2008
      Period”),
      issue
      any shares of Common Stock, stock appreciation rights, stock options or other
      equity securities (“New
      Equity”)
      to
      officers, directors or employees of, or consultants (that are affiliates of
      the
      Company)(“Affiliates”),
      provided, however, that, subject to the aggregate 10% limitation set forth
      above, the Company may issue New Equity during the one hundred eighty days
      following 2008 Period up to a maximum of 2% of the number of shares of Common
      Stock outstanding plus the number of shares of Common Stock issuable upon
      conversion of all outstanding preferred stock (the “Outstanding Amount”), if the
      Company meets between 100% and 149% of the “2007 Threshold” as defined below
      and, provided further, that, subject to such limitation, the Company may issue
      New Equity during the 2008 Period up to a maximum of 3% of the Outstanding
      Account, if the Company achieves at least 150% of the “2007 Threshold.”

     

    
      
        
        

      

      
        23

        
          

        

      

      
        
        

      

    

     

    (ii)
       between
      April 16, 2008 and April 15, 2009 (the “2009
      Period”),
      issue
      any New Equity to Affiliates, provided, however, that, subject to the aggregate
      10% limitation set forth above, the Company may issue New Equity during the
      one
      hundred eighty days following the 2009 Period up to a maximum of 2% of the
      Outstanding Amount, if the Company achieves at least 100% and 149% of the “2008
      Threshold,” as defined below; and provided further that, subject to such
      limitation, the Company may issue New Equity during 2009 up to a maximum of
      3%
      of the Outstanding Amount, if the Company achieves at least 150% of the “2008
      Threshold.”

     

    (A)
      “2007
      Performance Threshold” Definition:
      For the
      fiscal year ended December 31, 2007, earnings per share, as computed in
      accordance with US GAAP and reported by the Company in its audited financial
      statements for 2007 (the “2007
      financial statements”)
      shall
      equal or exceed $0.31, such “Earnings Per Share” to be calculated by dividing
the
      lesser
      of Net
      Income and Cash from Operations, as reported in the Company’s audited financial
      statements for the fiscal year ended December 31, 2007 (the “2007
      Financial Statements”)
      plus
      any
      amounts that may have been recorded as charges or liabilities on the 2007
      Financial Statements due to the application of EITF No. 00-19 that are
      associated with (1) any outstanding Warrants of the Company issued in connection
      with the Purchase Agreement or (2) any liabilities created as a result of any
      shares placed in escrow pursuant to the Purchase Agreement (the “Escrow
      Shares”)
      being
      released to any officers or directors of the Company (“2007
      Net Income”)
      by the
      aggregate number of shares of then outstanding Common Stock on a fully-diluted
      basis, which number shall include, without limitation, the number of shares
      of
      Common Stock issuable upon conversion of the Company’s then outstanding
      Preferred Shares and the number of shares of Common Stock issuable upon the
      exercise of any then outstanding preferred stock, warrants or options of the
      Company (“Outstanding
      Shares”).

     

    (B)
      “2008
      Performance Threshold” Definition.:
      For the
      fiscal year ending December 31, 2008, earnings per share shall equal or exceed
      $0.45, such “Earnings Per Share” to be calculated by dividing the
      lesser of
      Net
      Income and Cash from Operations, as reported by the Company in the Company’s
      audited financial statements for the fiscal year ending December 31, 2008 (the
      “2008
      Financial Statements”)
      plus
      any
      amounts that may have been recorded as charges or liabilities on the 2008
      Financial Statements due to the application of EITF No. 00-19 that are
      associated with (1) any outstanding Warrants of the Company issued in connection
      with the Purchase Agreement or (2) any liabilities created as a result of the
      Escrow Shares being released to any officers or directors of the Company
      (“2008
      Net Income”)
      by the
      then Outstanding Shares.  

     

    
      
        
        

      

      
        24

        
          

        

      

      
        
        

      

    

     

    (d)
       
      For so
      long as the Holders hold not less than the Minimum Holding, (i) the Company
      shall not issue any New Equity to Affiliates which does not qualify as an Exempt
      Issuance under Section 5(f)(vi) of the certificate of designations.

     

    (e)  
      Any
      awards made under such plan or exercises of such awards by the recipients
      thereof shall be deemed to be a Permitted Financing.

     

    Section
      3.18 Sarbanes-Oxley
      Act
      The
      Company shall be in compliance with the applicable provisions of the
      Sarbanes-Oxley Act of 2002, and the rules and regulations promulgated
      thereunder, as required under such Act.

     

    Section
      3.19 No
      Commissions in connection with Conversion of Preferred Shares
      In
      connection with the conversion of the Preferred Shares into Conversion Shares,
      neither the Company nor any Person acting on its behalf will take any action
      that would result in the Conversion Shares being exchanged by the Company other
      than with the then existing holders of the Preferred Shares exclusively where
      no
      commission or other remuneration is paid or given directly or indirectly for
      soliciting the exchange in compliance with Section 3(a)(9) of the Securities
      Act.

     

    ARTICLE
      IV

     

    CONDITIONS

     

    Section
      4.1  Conditions
      Precedent to the Obligation of the Company to Sell the Shares.
      The
      obligation hereunder of the Company to issue and sell the Units, and the
      underlying Preferred Shares and the Warrants to the Purchasers is subject to
      the
      satisfaction or waiver, at or before the applicable Closing, of each of the
      conditions set forth below. These conditions are for the Company’s sole benefit
      and may be waived by the Company at any time in its sole
      discretion.

     

    
      	(a)  	
              Accuracy
                of Each Purchaser’s Representations and Warranties.
                The representations and warranties of each Purchaser in this Agreement
                and
                each of the other Transaction Documents to which such Purchaser is
                a party
                shall be true and correct in all material respects as of the date
                when
                made and as of the applicable Closing Date as though made at that
                time,
                except for representations and warranties that are expressly made
                as of a
                particular date, which shall be true and correct in all material
                respects
                as of such date.

            

    

     

    
      	(b)  	
              Performance
                by the Purchasers.
                Each Purchaser shall have performed, satisfied and complied in all
                respects with all covenants, agreements and conditions required by
                this
                Agreement to be performed, satisfied or complied with by such Purchaser
                at
                or prior to the applicable Closing.

            

    

     

    
      
        
        

      

      
        25

        
          

        

      

      
        
        

      

    

     

    
      	(c)  	
              No
                Injunction.
                No statute, rule, regulation, executive order, decree, ruling or
                injunction shall have been enacted, entered, promulgated or endorsed
                by
                any court or governmental authority of competent jurisdiction which
                prohibits the consummation of any of the transactions contemplated
                by this
                Agreement

            

    

     

    
      	(d)  	
              Delivery
                of Purchase Price.
                The Purchase Price for the Units, the Preferred Shares and Warrants
                for
                the Initial Closing has been delivered to the escrow agent pursuant
                to the
                Closing Escrow Agreement.

            

    

     

    
      	(e)  	
              Delivery
                of Transaction Documents.
                The Transaction Documents to which the Purchasers are parties have
                been
                duly executed and delivered by the Purchasers to the
                Company.

            

    

     

    
      	(f)  	
              Share
                Exchange Transaction.
                Prior to the Initial Closing, the Share Exchange Transaction shall
                have
                been consummated.

            

    

     

    Section
      4.2  Conditions
      Precedent to the Obligation of the Purchasers to Purchase the
      Units.
      The
      obligation hereunder of each Purchaser to acquire and pay for the Units is
      subject to the satisfaction or waiver, at or before the applicable Closing,
      of
      each of the conditions set forth below. These conditions are for each
      Purchaser’s sole benefit and may be waived by such Purchaser at any time in its
      sole discretion.

     

    (a)  Accuracy
      of the Company’s Representations and Warranties.
      Each of
      the representations and warranties of the Company in this Agreement and the
      other Transaction Documents shall be true and correct in all respects as of
      the
      date when made and as of the applicable Closing Date as though made at that
      time
      (except for representations and warranties that are expressly made as of a
      particular date), which shall be true and correct in all respects as of such
      date.

     

    (b)  Performance
      by the Company.
      The
      Company shall have performed, satisfied and complied in all respects with all
      covenants, agreements and conditions required by this Agreement to be performed,
      satisfied or complied with by the Company at or prior to the applicable
      Closing.

     

    (c)  No
      Suspension, Etc.
      Quotation of the Common Stock shall not have been suspended by the Commission
      or
      the OTC Bulletin Board (except for any suspension of trading of limited duration
      agreed to by the Company, which suspension shall be terminated prior to the
      Closing), and, at any time prior to the Closing Date, trading in securities
      generally as reported by Bloomberg Financial Markets (“Bloomberg”)
      shall
      not have been suspended or limited, or minimum prices shall not have been
      established on securities whose trades are reported by Bloomberg, or on the
      New
      York Stock Exchange, nor shall a banking moratorium have been declared either
      by
      the United States or New York State authorities, nor shall there have occurred
      any material outbreak or escalation of hostilities or other national or
      international calamity or crisis of such magnitude in its effect on, or any
      material adverse change in any financial market which, in each case, in the
      judgment of such Purchaser, makes it impracticable or inadvisable to purchase
      the Preferred Shares.

     

    (d)  No
      Injunction.
      No
      statute, rule, regulation, executive order, decree, ruling or injunction shall
      have been enacted, entered, promulgated or endorsed by any court or governmental
      authority of competent jurisdiction which prohibits the consummation of any
      of
      the transactions contemplated by this Agreement.

     

    
      
        
        

      

      
        26

        
          

        

      

      
        
        

      

    

     

    (e)  No
      Proceedings or Litigation.
      No
      action, suit or proceeding before any arbitrator or any governmental authority
      shall have been commenced, and no investigation by any governmental authority
      shall have been threatened, against the Company or any subsidiary, or any of
      the
      officers, directors or affiliates of the Company or any subsidiary seeking
      to
      restrain, prevent or change the transactions contemplated by this Agreement,
      or
      seeking damages in connection with such transactions.

     

    (f)  Series
      A Certificate of Designation of Rights and Preferences.
      Prior
      to the Initial Closing, the Series A Certificate of Designation in the form
      of
      Exhibit B attached hereto shall have been filed with the Secretary of State
      of
      Delaware. 

     

    (g)  Opinions
      of Counsel, Etc.
      At the
      applicable Closing, the Purchasers shall have received an opinion of U.S.
      counsel to the Company, dated the date of the applicable Closing, in
      substantially the form of Exhibit H-1 hereto, and such other certificates and
      documents as the Purchasers or its counsel shall reasonably require incident
      to
      the applicable Closing. Four (4) days prior to the applicable Closing, the
      Purchasers shall have received an opinion of PRC counsel, dated the date of
      the
      applicable Closing with respect to the Entrustment Agreements and such other
      matters as the Purchasers may reasonably request, in substantially the form
      of
      Exhibit H-2 hereto. 

     

    (h)  Registration
      Rights Agreement.
      At the
      applicable Closing, the Company shall have executed and delivered the
      Registration Rights Agreement to each Purchaser in such Closing.

     

    (i)  Certificates.
      The
      Company shall have executed and delivered to the Purchasers the certificates
      (in
      such denominations as such Purchaser shall request) for the Preferred Shares
      and
      the Warrants being acquired by such Purchaser at the applicable Closing (in
      such
      denominations as such Purchaser shall request) to such address set forth next
      to
      each Purchasers name on Exhibit
      A
      hereto.

     

    (j)  Resolutions.
      The
      Board of Directors of the Company shall have adopted resolutions consistent
      with
      Section 2.1(b) hereof in a form reasonably acceptable to such Purchaser (the
      “Resolutions”).

     

    (k)  Reservation
      of Shares.
      As of
      the applicable Closing Date, the Company shall have reserved out of its
      authorized and unissued Common Stock, solely for the purpose of effecting the
      conversion of the Preferred Shares and the exercise of the Warrants, a number
      of
      shares of Common Stock equal to one hundred fifty percent (150%) of the
      aggregate number of Conversion Shares issuable upon conversion of the Preferred
      Shares issued or to be issued pursuant to this Agreement and the number of
      Warrant Shares issuable upon exercise of the number of Warrants issued or to
      be
      issued pursuant to this Agreement.

     

    (l)  Transfer
      Agent Instructions.
      As of
      the Initial Closing Date, the Irrevocable Transfer Agent Instructions, in the
      form of Exhibit G attached hereto, shall have been delivered to and acknowledged
      in writing by the Company’s transfer agent.

     

    
      
        
        

      

      
        27

        
          

        

      

      
        
        

      

    

     

    (m)  Lock-Up
      Agreement.
      As of
      the Initial Closing Date, the persons listed on Schedule
      3.12
      hereto
      shall have delivered to the Purchasers a fully executed Lock-Up Agreement in
      the
      form of Exhibit
      E
      attached
      hereto.

     

    (n)  Secretary’s
      Certificate.
      The
      Company shall have delivered to such Purchaser a secretary’s certificate, dated
      as of the applicable Closing Date, as to (i) the Resolutions, (ii) the Articles,
      (iii) the Bylaws, (iv) the Series A Certificate of Designation, each as in
      effect at the applicable Closing, and (iv) the authority and incumbency of
      the
      officers of the Company executing the Transaction Documents and any other
      documents required to be executed or delivered in connection
      therewith.

     

    (o)  Officer’s
      Certificate.
      The
      Company shall have delivered to the Purchasers a certificate of an executive
      officer of the Company, dated as of the applicable Closing Date, confirming
      the
      accuracy of the Company’s representations, warranties and covenants as of the
      applicable Closing Date and confirming the compliance by the Company with the
      conditions precedent set forth in this Section 4.2 as of the applicable Closing
      Date.

     

    (p)  General
      Escrow Agreement.
      At the
      Initial Closing, the Company and the escrow agent shall have executed and
      delivered the General Escrow Agreement in the form of Exhibit
      F-1
      attached
      hereto to each Purchaser.

     

    (q)  Securities
      Escrow Agreement.
      The
      Securities Escrow Agreement shall have been executed by the parties thereto
      and
      the Escrow Shares (as defined in the Securities Escrow Agreement) shall have
      been deposited into the escrow account pursuant to the terms of the Securities
      Escrow Agreement in the form of Exhibit
      F-2
      attached
      hereto.

     

    (r)  Material
      Adverse Effect.
      No
      Material Adverse Effect shall have occurred at or before the Closing
      Date.

     

    (s)  Share
      Exchange Transaction.
      Prior
      to the Initial Closing, the Share Exchange Transaction shall have been
      consummated in accordance with the Exchange Agreement, a copy of which is
      attached hereto as Exhibit K.

     

    ARTICLE
      V

     

    Stock
      Certificate Legend

     

    Section
      5.1  Legend.
      Each
      certificate representing the Preferred Shares and the Warrants, and, if
      appropriate, securities issued upon conversion thereof, shall be stamped or
      otherwise imprinted with a legend substantially in the following form (in
      addition to any legend required by applicable state securities or “blue sky”
laws):

     

    THESE
      SECURITIES REPRESENTED BY THIS CERTIFICATE (THE “SECURITIES”) HAVE NOT BEEN
      REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”)
      OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE
      DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE
      STATE SECURITIES LAWS OR THE COMPANY SHALL HAVE RECEIVED AN OPINION OF COUNSEL
      THAT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND UNDER THE
      PROVISIONS OF APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED.

     

    
      
        
        

      

      
        28

        
          

        

      

      
        
        

      

    

    

    The
      Company agrees to reissue certificates representing any of the Conversion Shares
      and the Warrant Shares, without the legend set forth above if at such time,
      prior to making any transfer of any such securities, such holder thereof shall
      give written notice to the Company describing the manner and terms of such
      transfer and removal as the Company may reasonably request. Such proposed
      transfer and removal will not be effected until: (a) either (i) the Company
      has
      received an opinion of counsel reasonably satisfactory to the Company, to the
      effect that the registration of the Conversion Shares or the Warrant Shares
      under the Securities Act is not required in connection with such proposed
      transfer, (ii) a registration statement under the Securities Act covering such
      proposed disposition has been filed by the Company with the Commission and
      has
      become effective under the Securities Act, (iii) the Company has received other
      evidence reasonably satisfactory to the Company that such registration and
      qualification under the Securities Act and state securities laws are not
      required, or (iv) the holder provides the Company with reasonable assurances
      that such security can be sold pursuant to Rule 144 under the Securities Act;
      and (b) either (i) the Company has received an opinion of counsel reasonably
      satisfactory to the Company, to the effect that registration or qualification
      under the securities or “blue sky” laws of any state is not required in
      connection with such proposed disposition, or (ii) compliance with applicable
      state securities or “blue sky” laws has been effected or a valid exemption
      exists with respect thereto. The Company will respond to any such notice from
      a
      holder within five (5) business days. In the case of any proposed transfer
      under
      this Section 5.1, the Company will use reasonable efforts to comply with any
      such applicable state securities or “blue sky” laws, but shall in no event be
      required, (x) to qualify to do business in any state where it is not then
      qualified, (y) to take any action that would subject it to tax or to the general
      service of process in any state where it is not then subject, or (z) to comply
      with state securities or “blue sky” laws of any state for which registration by
      coordination is unavailable to the Company. The restrictions on transfer
      contained in this Section 5.1 shall be in addition to, and not by way of
      limitation of, any other restrictions on transfer contained in any other section
      of this Agreement. Whenever a certificate representing the Conversion Shares
      or
      Warrant Shares is required to be issued to a Purchaser without a legend, in
      lieu
      of delivering physical certificates representing the Conversion Shares or
      Warrant Shares (provided that a registration statement under the Securities
      Act
      providing for the resale of the Warrant Shares and Conversion Shares is then
      in
      effect), the Company may cause its transfer agent to electronically transmit
      the
Conversion Shares or Warrant Shares to a Purchaser by crediting the account
      of
      such Purchaser or such Purchaser’s Prime Broker with the Depository Trust
      Company (“DTC”)
      through its Deposit Withdrawal Agent Commission (“DWAC”)
      system
      (to the extent not inconsistent with any provisions of this
      Agreement).

    

    The
      Company acknowledges and agrees that an Investor may from time to time pledge,
      and/or grant a security interest in some or all of the Securities pursuant
      to a
      bona fide margin agreement in connection with a bona fide margin account and,
      if
      required under the terms of such agreement or account, such Investor may
      transfer pledged or secured Securities to the pledgees or secured parties.
      Such
      a pledge or transfer would not be subject to approval or consent of the Company
      and no legal opinion of legal counsel to the pledgee, secured party or pledgor
      shall be required in connection with the pledge, but such legal opinion may
      be
      required in connection with a subsequent transfer following default by the
      Investor transferee of the pledge. No notice shall be required of such pledge.
      At the appropriate Investor’s expense, the Company will execute and deliver such
      reasonable documentation as a pledgee or secured party of Securities may
      reasonably request in connection with a pledge or transfer thereof including
      the
      preparation and filing of any required prospectus supplement under Rule
      424(b)(3) of the Securities Act or other applicable provision of the Securities
      Act to appropriately amend the list of selling stockholders thereunder. Except
      as otherwise provided in Section 5.1, any Securities subject to a pledge or
      security interest as contemplated by this Section 5.1 shall continue to bear
      the
      legend set forth in this Section 5.1 and be subject to the restrictions on
      transfer set forth in Section 5.1.

     

    
      
        
        

      

      
        29

        
          

        

      

      
        
        

      

    

    

    Certificates
      or instruments evidencing Securities shall not contain any legend (including
      the
      legend set forth in Section 5.1): (i) following their disposition pursuant
      to an
      effective registration statement (including the Registration Statement with
      respect to the Shares and the Warrant Shares), or (ii) following a sale or
      transfer of such Securities pursuant to Rule 144 (assuming the transferee is
      not
      an Affiliate of the Company), or (iii) while such Securities are eligible for
      sale by the selling Investor without volume restrictions under Rule 144. If
      an
      Investor shall make a sale or transfer of Securities either (x) pursuant to
      Rule
      144 or (y) pursuant to a registration statement and in each case shall have
      delivered to the Company or the Transfer Agent the certificate or instrument
      representing the applicable Securities containing a restrictive legend which
      are
      the subject of such sale or transfer and a representation letter in customary
      form (the
      date
      of such sale or transfer and Securities delivery being the “Share Delivery
      Date”) and (1) the Company shall fail to deliver or cause to be delivered to
      such Investor a certificate or instrument representing such Securities that
      is
      free from all restrictive or other legends by the fifth Trading Day following
      the Share Delivery Date and (2) following such fifth Trading Day after the
      Share
      Delivery Date and prior to the time such Securities are received free from
      restrictive legends, the Investor, or any third party on behalf of such
      Investor, purchases (in an open market transaction or otherwise) shares of
      Common Stock to deliver in satisfaction of a sale by the Investor of such
      Securities (a "Buy-In"), then, in addition to any other rights available to
      the
      Investor under the Transaction Documents and applicable law, the Company shall
      pay in cash to the Investor (for costs incurred either directly by such Investor
      or on behalf of a third party) the amount by which the total purchase price
      paid
      for Common Stock as a result of the Buy-In (including brokerage commissions,
      if
      any) exceed the proceeds received by such Investor as a result of the sale
      to
      which such Buy-In relates. The Investor shall provide the Company written notice
      indicating the amounts payable to the Investor in respect of the Buy-In. The
      Company may not make any notation on its records or give instructions to any
      transfer agent of the Company that enlarge the restrictions on transfer set
      forth in this Section.

     

    
      
        
        

      

      
        30

        
          

        

      

      
        
        

      

    

     

    ARTICLE
      VI

     

    Indemnification

     

    Section
      6.1  General
      Indemnity.
      The
      Company agrees to indemnify and hold harmless the Purchasers (and their
      respective directors, officers, managers, partners, members, shareholders,
      affiliates, agents, successors and assigns) from and against any and all losses,
      liabilities, deficiencies, costs, damages and expenses (including, without
      limitation, reasonable attorneys’ fees, charges and disbursements) incurred by
      the Purchasers as a result of any inaccuracy in or breach of the
      representations, warranties or covenants made by the Company herein. Each
      Purchaser severally but not jointly agrees to indemnify and hold harmless the
      Company and its directors, officers, affiliates, agents, successors and assigns
      from and against any and all losses, liabilities, deficiencies, costs, damages
      and expenses (including, without limitation, reasonable attorneys’ fees, charges
      and disbursements) incurred by the Company as a result of any inaccuracy in
      or
      breach of the representations, warranties or covenants made by such Purchaser
      herein. The maximum aggregate liability of each Purchaser pursuant to its
      indemnification obligations under this Article VII shall not exceed the portion
      of the Purchase Price paid by such Purchaser hereunder.

     

    Section
      6.2  Indemnification
      Procedure.
      Any
      party entitled to indemnification under this Article VI (an “indemnified party”)
      will give written notice to the indemnifying party of any matters giving rise
      to
      a claim for indemnification; provided,
      that
      the failure of any party entitled to indemnification hereunder to give notice
      as
      provided herein shall not relieve the indemnifying party of its obligations
      under this Article VI except to the extent that the indemnifying party is
      actually prejudiced by such failure to give notice. In case any action,
      proceeding or claim is brought against an indemnified party in respect of which
      indemnification is sought hereunder, the indemnifying party shall be entitled
      to
      participate in and, unless in the reasonable judgment of the indemnified party
      a
      conflict of interest between it and the indemnifying party may exist with
      respect of such action, proceeding or claim, to assume the defense thereof
      with
      counsel reasonably satisfactory to the indemnified party. In the event that
      the
      indemnifying party advises an indemnified party that it will contest such a
      claim for indemnification hereunder, or fails, within thirty (30) days of
      receipt of any indemnification notice to notify, in writing, such person of
      its
      election to defend, settle or compromise, at its sole cost and expense, any
      action, proceeding or claim (or discontinues its defense at any time after
      it
      commences such defense), then the indemnified party may, at its option, defend,
      settle or otherwise compromise or pay such action or claim. In any event, unless
      and until the indemnifying party elects in writing to assume and does so assume
      the defense of any such claim, proceeding or action, the indemnified party’s
      costs and expenses arising out of the defense, settlement or compromise of
      any
      such action, claim or proceeding shall be losses subject to indemnification
      hereunder. The indemnified party shall cooperate fully with the indemnifying
      party in connection with any negotiation or defense of any such action or claim
      by the indemnifying party and shall furnish to the indemnifying party all
      information reasonably available to the indemnified party which relates to
      such
      action or claim. The indemnifying party shall keep the indemnified party fully
      apprised at all times as to the status of the defense or any settlement
      negotiations with respect thereto. If the indemnifying party elects to defend
      any such action or claim, then the indemnified party shall be entitled to
      participate in such defense with counsel of its choice at its sole cost and
      expense. The indemnifying party shall not be liable for any settlement of any
      action, claim or proceeding effected without its prior written consent.
      Notwithstanding anything in this Article VI to the contrary, the indemnifying
      party shall not, without the indemnified party’s prior written consent, settle
      or compromise any claim or consent to entry of any judgment in respect thereof
      which imposes any future obligation on the indemnified party or which does
      not
      include, as an unconditional term thereof, the giving by the claimant or the
      plaintiff to the indemnified party of a release from all liability in respect
      of
      such claim. The indemnification required by this Article VI shall be made by
      periodic payments of the amount thereof during the course of investigation
      or
      defense, as and when bills are received or expense, loss, damage or liability
      is
      incurred, so long as the indemnified party irrevocably agrees to refund such
      moneys if it is ultimately determined by a court of competent jurisdiction
      that
      such party was not entitled to indemnification. The indemnity agreements
      contained herein shall be in addition to (a) any cause of action or similar
      rights of the indemnified party against the indemnifying party or others, and
      (b) any liabilities the indemnifying party may be subject to pursuant to the
      law.

     

    
      
        
        

      

      
        31

        
          

        

      

      
        
        

      

    

     

    ARTICLE
      VII

     

    Miscellaneous

     

    Section
      7.1  Fees
      and Expenses.
      Except
      as otherwise set forth in this Agreement and the other Transaction Documents,
      each party shall pay the fees and expenses of its advisors, counsel, accountants
      and other experts, if any, and all other expenses, incurred by such party
      incident to the negotiation, preparation, execution, delivery and performance
      of
      this Agreement, provided that the Company shall pay all actual and reasonable
      attorneys’ fees and expenses (including disbursements and out-of-pocket
      expenses) up to a maximum of $20,000 incurred by the Purchasers in connection
      with the preparation, negotiation, execution and delivery of this Agreement
      and
      the other Transaction Documents and the consummation of the transactions and
      the
      review of the Restructuring Agreements.

     

    Section
      7.2  Specific
      Enforcement, Consent to Jurisdiction.
      

     

    (a)  The
      Company and the Purchasers acknowledge and agree that irreparable damage would
      occur in the event that any of the provisions of this Agreement or the other
      Transaction Documents were not performed in accordance with their specific
      terms
      or were otherwise breached. It is accordingly agreed that the parties shall
      be
      entitled to an injunction or injunctions to prevent or cure breaches of the
      provisions of this Agreement or the other Transaction Documents and to enforce
      specifically the terms and provisions hereof or thereof, this being in addition
      to any other remedy to which any of them may be entitled by law or
      equity.

     

    (b)  Each
      of
      the Company and the Purchasers (i) hereby irrevocably submits to the
      jurisdiction of the United States District Court sitting in the Southern
      District of New York and the courts of the State of New York located in New
      York
      county for the purposes of any suit, action or proceeding arising out of or
      relating to this Agreement or any of the other Transaction Documents or the
      transactions contemplated hereby or thereby and (ii) hereby waives, and agrees
      not to assert in any such suit, action or proceeding, any claim that it is
      not
      personally subject to the jurisdiction of such court, that the suit, action
      or
      proceeding is brought in an inconvenient forum or that the venue of the suit,
      action or proceeding is improper. Each of the Company and the Purchasers
      consents to process being served in any such suit, action or proceeding by
      mailing a copy thereof to such party at the address in effect for notices to
      it
      under this Agreement and agrees that such service shall constitute good and
      sufficient service of process and notice thereof. Nothing in this Section 7.2
      shall affect or limit any right to serve process in any other manner permitted
      by law.

     

    
      
        
        

      

      
        32

        
          

        

      

      
        
        

      

    

     

    Section
      7.3  Entire
      Agreement; Amendment.
      This
      Agreement and the other Transaction Documents contains the entire understanding
      and agreement of the parties with respect to the matters covered hereby and,
      except as specifically set forth herein or in the Transaction Documents, neither
      the Company nor any of the Purchasers makes any representations, warranty,
      covenant or undertaking with respect to such matters and they supersede all
      prior understandings and agreements with respect to said subject matter, all
      of
      which are merged herein. No provision of this Agreement may be waived or amended
      other than by a written instrument signed by the Company and the holders of
      at
      least seventy-five percent (75%) of the Preferred Shares then outstanding,
      and
      no provision hereof may be waived other than by an a written instrument signed
      by the party against whom enforcement of any such amendment or waiver is sought.
      No such amendment shall be effective to the extent that it applies to less
      than
      all of the holders of the Preferred Shares then outstanding. No consideration
      shall be offered or paid to any person to amend or consent to a waiver or
      modification of any provision of any of the Transaction Documents unless the
      same consideration is also offered to all of the parties to the Transaction
      Documents or holders of Preferred Shares, as the case may be.

     

    Section
      7.4  Notices.
      Any
      notice, demand, request, waiver or other communication required or permitted
      to
      be given hereunder shall be in writing and shall be effective (a) upon hand
      delivery by telex (with correct answer back received), telecopy or facsimile
      at
      the address or number designated below (if delivered on a business day during
      normal business hours where such notice is to be received), or the first
      business day following such delivery (if delivered other than on a business
      day
      during normal business hours where such notice is to be received) or (b) on
      the
      second business day following the date of mailing by express courier service,
      fully prepaid, addressed to such address, or upon actual receipt of such
      mailing, whichever shall first occur. The addresses for such communications
      shall be:

     

    
      	
              If
                to the Company: 

            	 
	 	 
	 	
              Mr.
                Chen Zhong

            
	 	
              Aamaxan
                Transport Group, Inc.

            
	 	
              Suite
                6B, 1440 Hongqiao Road

            
	 	
              Changning
                District

            
	 	
              Shanghai

            
	 	
              PRC

            
	 	
              Tel.
                No.: 86-21-508-05-789

            
	 	
              Fax
                No.: 86-21-508-02-149

            
	 	 
	
              with
                copies to:

            	 
	 	
              Guzov
                Ofsink, LLC

            
	 	
              600
                Madison Avenue, 14th Floor

            
	 	
              New
                York, New York 10022

            
	 	
              Attention:
                Darren Ofsink

            
	 	
              Tel.
                No.: (212) 371-8008, ext. 102

            
	 	
              Fax
                No.: (212) 688-7273

            

    

     

    
      
        
        

      

      
        33

        
          

        

      

      
        
        

      

    

     

    
      	
              If
                to any Purchaser: 

            	
              At
                the address of such Purchaser set forth on Exhibit A to this Agreement,
                with copies to Purchaser’s counsel as set forth on Exhibit A or as
                specified in writing by such Purchaser with copies to:

            
	 	 
	 	
              Wells
                Moore Simmons & Hubbard PLLC 

            
	 	
              P.O.
                Box 1970

            
	 	
              Jackson,
                MS 39215-1970

            
	 	
              Attention.:
                Nash Neyland

            
	 	
              Phone:(601)
                354-5400

            
	 	
              Fax:
                (601) 355-5850

            

    

     

    Any
      party
      hereto may from time to time change its address for notices by giving at least
      ten (10) days written notice of such changed address to the other party
      hereto.

     

    Section
      7.5  Waivers.
      No
      waiver by either party of any default with respect to any provision, condition
      or requirement of this Agreement shall be deemed to be a continuing waiver
      in
      the future or a waiver of any other provisions, condition or requirement hereof,
      nor shall any delay or omission of any party to exercise any right hereunder
      in
      any manner impair the exercise of any such right accruing to it
      thereafter.

     

    Section
      7.6  Headings.
      The
      article, section and subsection headings in this Agreement are for convenience
      only and shall not constitute a part of this Agreement for any other purpose
      and
      shall not be deemed to limit or affect any of the provisions
      hereof.

     

    Section
      7.7  Successors
      and Assigns.
      This
      Agreement shall be binding upon and inure to the benefit of the parties and
      their successors and assigns.

     

    Section
      7.8  No
      Third Party Beneficiaries.
      This
      Agreement is intended for the benefit of the parties hereto and their respective
      permitted successors and assigns and is not for the benefit of, nor may any
      provision hereof be enforced by, any other person.

     

    Section
      7.9  Governing
      Law.
      This
      Agreement shall be governed by and construed in accordance with the internal
      laws of the State of New York, without giving effect to any of the conflicts
      of
      law principles which would result in the application of the substantive law
      of
      another jurisdiction. This Agreement shall not be interpreted or construed
      with
      any presumption against the party causing this Agreement to be
      drafted.

     

    Section
      7.10  Survival.
      The
      representations and warranties of the Company and the Purchasers shall survive
      the execution and delivery hereof and the Closings hereunder for a period of
      two
      years following the Closing Date.

     

    Section
      7.11  Counterparts.
      This
      Agreement may be executed in any number of counterparts, each of which when
      so
      executed shall be deemed to be an original and, all of which taken together
      shall constitute one and the same Agreement and shall become effective when
      counterparts have been signed by each party and delivered to the other parties
      hereto, it being understood that all parties need not sign the same counterpart.
      In the event that any signature is delivered by facsimile transmission, such
      signature shall create a valid binding obligation of the party executing (or
      on
      whose behalf such signature is executed) the same with the same force and effect
      as if such facsimile signature were the original thereof.

     

    
      
        
        

      

      
        34

        
          

        

      

      
        
        

      

    

     

    Section
      7.12  Publicity.
      The
      Company agrees that it will not disclose, and will not include in any public
      announcement, the name of the Purchasers without the consent of the Purchasers
      unless and until such disclosure is required by law or applicable regulation,
      and then only to the extent of such requirement.

     

    Section
      7.13  Severability.
      The
      provisions of this Agreement and the Transaction Documents are severable and,
      in
      the event that any court of competent jurisdiction shall determine that any
      one
      or more of the provisions or part of the provisions contained in this Agreement
      or the Transaction Documents shall, for any reason, be held to be invalid,
      illegal or unenforceable in any respect, such invalidity, illegality or
      unenforceability shall not affect any other provision or part of a provision
      of
      this Agreement or the Transaction Documents and such provision shall be reformed
      and construed as if such invalid or illegal or unenforceable provision, or
      part
      of such provision, had never been contained herein, so that such provisions
      would be valid, legal and enforceable to the maximum extent
      possible.

     

    Section
      7.14  Further
      Assurances.
      From
      and after the date of this Agreement, upon the request of any Purchaser or
      the
      Company, each of the Company and the Purchasers shall execute and deliver such
      instrument, documents and other writings as may be reasonably necessary or
      desirable to confirm and carry out and to effectuate fully the intent and
      purposes of this Agreement, the Preferred Shares, the Conversion Shares, the
      Warrants, the Warrant Shares, the Series A Certificate of Designation, the
      Registration Rights Agreement and the other Transaction Documents.

     

    IN
      WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly
      executed by their respective authorized officer as of the date first above
      written.

    

    
      	
              AAMAXAN
                TRANSPORT GROUP, INC.

            
	 
	
              By:
                 

            	
               

            
	 	
              
                Name:

              

            
	 	
              Title:

            
	 	 
	
              PURCHASER

            
	 	 
	 	 
	
              
                POPE
                  INVESTMENTS II LLC

              

            
	 
	 
	
              By:
                 

            	
               

            
	 	
              
                Name:

              

            
	 	
              Title: 

            

    

     

    
      
        
        

      

      
        35

        
          

        

      

      
        
        

      

       

    

    
      	
              OTHER
                PURCHASER:

            
	 	
              _______________________________

            
	 	
              (Name
                of Other Purchaser)

            
	 	 
	
              By:
                

            	
               

            
	 	
              
                Name:

              

            
	 	
              Title: 

            

    

     

    
      
        
        

      

      
        36

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      A TO THE

    SECURITIES
      PURCHASE AGREEMENT

    ______________________________________________

     

    
      	
              Investor
                and Address

            	 	
              Investment

            	 	
              Units
                

              Purchased

            	 	
              Shares
                of 

              Preferred
                

              Stock

            	 	
              Series
                A 

              Warrants

            

    

     

    
      
        
        

      

      
        37

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      B TO THE 

    SECURITIES
      PURCHASE AGREEMENT

    _________________________________________________

     

    FORM
      OF SERIES A CERTIFICATE OF DESIGNATION

     

    
      
        
        

      

      
        38

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      C-1 TO THE

    SECURITIES
      PURCHASE AGREEMENT 

    _______________________________________________

     

    FORM
      OF SERIES A WARRANT

     

    
      
        
        

      

      
        39

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      D TO THE 

    SECURITIES
      PURCHASE AGREEMENT

    _________________________________________________

     

    FORM
      OF REGISTRATION RIGHTS AGREEMENT

     

    
      
        
        

      

      
        40

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      E TO THE 

    SECURITIES
      PURCHASE AGREEMENT

    __________________________________________

     

    FORM
      OF LOCK-UP AGREEMENT

     

    
      
        
        

      

      
        41

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      F-1 TO THE 

    SECURITIES
      PURCHASE AGREEMENT

    _______________________________________

     

    FORM
      OF GENERAL ESCROW AGREEMENT

     

    
      
        
        

      

      
        42

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      F-2 TO THE 

    SECURITIES
      PURCHASE AGREEMENT

    _______________________________________

     

    FORM
      OF SECURITIES ESCROW AGREEMENT

    
      
        
        

      

      
        43

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      F-3 TO THE 

    SECURITIES
      PURCHASE AGREEMENT

    _______________________________________

     

    FORM
      OF CLOSING ESCROW AGREEMENT

     

    
      
        
        

      

      
        44

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      G TO THE 

    SECURITIES
      PURCHASE AGREEMENT

    ____________________________________________

     

    FORM
      OF IRREVOCABLE TRANSFER AGENT INSTRUCTIONS

    ___________________________________________

     

    as
      of
      ____________, 2008

     

    [Name
      and address of Transfer Agent]

    Attn:
      _____________

     

    Ladies
      and Gentlemen:

     

    Reference
      is made to that certain Securities Purchase Agreement (the “Purchase
      Agreement”),
      dated
      as of April 10, 2008, by and among .............................., a Delaware corporation (the
“Company”),
      and
      the purchasers named therein (collectively, the “Purchasers”)
      pursuant to which the Company is issuing to the Purchasers shares of its Series
      A Senior Convertible Preferred Stock, par value $.001 per share, (the
“Preferred
      Shares”)
      and
      warrants (the “Warrants”)
      to
      purchase shares of the Company’s common stock, par value $.0001 per share (the
“Common
      Stock”).
      This
      letter shall serve as our irrevocable authorization and direction to you
      provided that you are the transfer agent of the Company at such time) to issue
      shares of Common Stock upon conversion of the Preferred Shares (the
“Conversion
      Shares”)
      and
      exercise of the Warrants (the “Warrant
      Shares”)
      to or
      upon the order of a Purchaser from time to time upon (i) surrender to you
      of a properly completed and duly executed Conversion Notice or Exercise Notice,
      as the case may be, in the form attached hereto as Exhibit I and Exhibit II,
      respectively, (ii) in the case of the conversion of Preferred Shares, a
      copy of the certificates (with the original certificates delivered to the
      Company) representing Preferred Shares being converted or, in the case of
      Warrants being exercised, a copy of the Warrants (with the original Warrants
      delivered to the Company) being exercised (or, in each case, an indemnification
      undertaking with respect to such share certificates or the warrants in the
      case
      of their loss, theft or destruction), and (iii) delivery of a treasury
      order or other appropriate order duly executed by a duly authorized officer
      of
      the Company. So long as you have previously received (x) written confirmation
      from counsel to the Company that a registration statement covering resales
      of
      the Conversion Shares or Warrant Shares, as applicable, has been declared
      effective by the Securities and Exchange Commission (the “SEC”)
      under
      the Securities Act of 1933, as amended (the “1933
      Act”),
      and
      no subsequent notice by the Company or its counsel of the suspension or
      termination of its effectiveness and (y) a copy of such registration statement,
      and if the Purchaser represents in writing that the Conversion Shares or the
      Warrant Shares, as the case may be, were sold pursuant to the Registration
      Statement, then certificates representing the Conversion Shares and the Warrant
      Shares, as the case may be, shall not bear any legend restricting transfer
      of
      the Conversion Shares and the Warrant Shares, as the case may be, thereby and
      should not be subject to any stop-transfer restriction. Provided, however,
      that
      if you have not previously received those items and representations listed
      above, then the certificates for the Conversion Shares and the Warrant Shares
      shall bear the following legend:

     

    
      
        
        

      

      
        45

        
          

        

      

      
        
        

      

    

     

    “THE
      SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT”), OR ANY STATE
      SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS
      REGISTERED UNDER THE SECURITIES ACT OR APPLICABLE STATE SECURITIES LAWS, OR
      THE
      COMPANY SHALL HAVE RECEIVED AN OPINION OF ITS COUNSEL THAT REGISTRATION OF
      SUCH
      SECURITIES UNDER THE SECURITIES ACT AND UNDER THE PROVISIONS OF APPLICABLE
      STATE
      SECURITIES LAWS IS NOT REQUIRED.”

     

    and,
      provided, further, that the Company may from time to time notify you to place
      stop-transfer restrictions on the certificates for the Conversion Shares and
      the
      Warrant Shares in the event a registration statement covering the Conversion
      Shares and the Warrant Shares is subject to amendment for events then
      current.

     

    A
      form of
      written confirmation from counsel to the Company that a registration statement
      covering resales of the Conversion Shares and the Warrant Shares has been
      declared effective by the SEC under the 1933 Act is attached hereto as Exhibit
      III.

     

    Please
      be
      advised that the Purchasers are relying upon this letter as an inducement to
      enter into the Purchase Agreement and, accordingly, each Purchaser is a third
      party beneficiary to these instructions.

     

    Please
      execute this letter in the space indicated to acknowledge your agreement to
      act
      in accordance with these instructions. Should you have any questions concerning
      this matter, please contact me at ___________.

    

    
      	
              Very
                truly yours,

            
	
              [______________________________________]

            
	
              By: ____________________________________

            
	
              Name:
                __________________________________

            
	
              Title:  
                __________________________________

            

    

     

    
      
        
        

      

      
        46

        
          

        

      

      
        
        

      

    

     

    ACKNOWLEDGED
      AND AGREED:

     

    [TRANSFER
      AGENT]

    

    
      	
              By:
                

            	 
	
              Name:
                

            	 
	
              Title:
                

            	 
	
              Date:
                

            	 

    

    
      
        
        

      

      
        47

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      I

    _____________________________________________

     

    CONVERSION
      NOTICE

     

    Reference
      is made to the Series A Certificate of Designation of the Relative Rights and
      Preferences of the Series A Senior Convertible Preferred Stock of ________________________(the
      “Series A Certificate of Designation”). In accordance with and pursuant to the
      Series A Certificate of Designation, the undersigned hereby elects to convert
      the number of shares of Series A Senior Convertible Preferred Stock, par value
      $.001 per share (the “Preferred Shares”),
      of                              ,
      a
      Delaware corporation (the “Company”), indicated below into shares of Common
      Stock, par value $.0001 per share (the “Common Stock”), of the Company, by
      tendering the stock certificate(s) representing the share(s) of Preferred Shares
      specified below as of the date specified below.

     

    
      	
              Date
                of Conversion: 

            	
              ______________________________________

            
	 	 
	
              Number
                of Preferred Shares to be converted: 

            	
              _________

            
	 	 
	
              Stock
                certificate no(s). of Preferred Shares to be converted:
                    

            	
              ________

            

    

     

    The
      Common Stock have been sold pursuant to the Registration Statement (as defined
      in the Registration Rights Agreement): YES _______ NO______

     

    Please
      confirm the following information:

     

    
      	
              Conversion
                Price: 

            	
              _______________________________________

            
	 	
               

            
	
              Number of shares of Common Stock to be issued:
                

            	
              _______________________________________

            

    

     

    Number
      of
      shares of Common Stock beneficially owned or deemed beneficially owned by the
      Holder on the Date of Conversion: _____________________

     

    Please
      issue the Common Stock into which the Preferred Shares are being converted
      and,
      if applicable, any check drawn on an account of the Company in the following
      name and to the following address:

    

    
      	
              Issue
                to: 

            	_____________________
	 	_____________________ 
	
              Facsimile
                Number:

            	_____________________

    

     

    
      
        
        

      

      
        48

        
          

        

      

      
        
        

      

    

     

    
      	
              Authorization:

            	_____________________ 
	 	 
	 	
              By:
                

            	_____________________
	 	
              Title:
                

            	_____________________ 
	
              Dated:

            	 	 

    

     

    
      
        
        

      

      
        49

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      II

     

    FORM
      OF EXERCISE NOTICE

     

    EXERCISE
      FORM

     

    ____________________________________________

     

    The
      undersigned____________, pursuant to the provisions of the within Warrant,
      hereby elects to purchase ______ shares of Common Stock of _ ................................
      covered by the within Warrant.

     

    
      	
              Dated:
                

            	__________________________________	
              Signature
                

            	__________________________________________
	 	 	 	 
	 	 	
              Address

            	__________________________________________
	 	 	__________________________________________________

    

     

    Number
      of
      shares of Common Stock beneficially owned or deemed beneficially owned by the
      Holder on the date of Exercise: _______________________

     

    ASSIGNMENT

     

    FOR
      VALUE
      RECEIVED, ________________ hereby sells, assigns and transfers unto
      _______________ the within Warrant and all rights evidenced thereby and does
      irrevocably constitute and appoint ______________, attorney, to transfer the
      said Warrant on the books of the within named corporation.

     

      	
              Dated:
                

            	__________________________________	
              Signature
                

            	__________________________________________
	 	 	 	 
	 	 	
              Address

            	__________________________________________
	 	 	__________________________________________________

    

     

    PARTIAL
      ASSIGNMENT

     

    FOR
      VALUE
      RECEIVED, ________________ hereby sells, assigns and transfers unto
      _______________ the right to purchase ___________ shares of Warrant Stock
      evidenced by the within Warrant together with all rights therein, and does
      irrevocably constitute and appoint __________________, attorney, to transfer
      that part of the said Warrant on the books of the within named
      corporation.

     

    
      	
              Dated:
                

            	__________________________________	
              Signature
                

            	__________________________________________
	 	 	 	 
	 	 	
              Address

            	__________________________________________
	 	 	__________________________________________________

    

     

    
      
        
        

      

      
        50

        
          

        

      

      
        
        

      

    

     

    FOR
      USE
      BY THE ISSUER ONLY:

     

    This
      Warrant No. W-_________ canceled (or transferred or exchanged) this _______
      day
      of __________, _______, shares of Common Stock issued therefor in the name
      of
      _______________, Warrant No. W-______ issued for _______ shares of Common Stock
      in the name of ________________.

     

    
      
        
        

      

      
        51

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      III

     

    FORM
      OF NOTICE OF EFFECTIVENESS

    OF
      REGISTRATION STATEMENT

     

    [Name
      and address of Transfer Agent]

     

    Attn:
      _________

     

    Re:
      [__________________________________]

     

    Ladies
      and Gentlemen:

     

    We
      are
      counsel to Aamaxan Transport Group, Inc., a Delaware corporation (the
“Company”),
      and
      have represented the Company in connection with that certain Series A Senior
      Convertible Preferred Stock Purchase Agreement (the “Purchase
      Agreement”),
      dated
      as of April 10, 2008, by and among the Company and the purchasers named therein
      (collectively, the “Purchasers”)
      pursuant to which the Company issued to the Purchasers shares of its Series
      A
      Senior Convertible Preferred Stock, par value $.001 per share, (the
“Preferred
      Shares”)
      and
      warrants (the “Warrants”)
      to
      purchase shares of the Company’s common stock, par value $.0001 per share (the
“Common
      Stock”).
      Pursuant to the Purchase Agreement, the Company has also entered into a
      Registration Rights Agreement with the Purchasers (the “Registration
      Rights Agreement”),
      dated
      as of April 10, 2008, pursuant to which the Company agreed, among other things,
      to register the Registrable Securities (as defined in the Registration Rights
      Agreement), including the shares of Common Stock issuable upon conversion of
      the
      Preferred Shares and exercise of the Warrants, under the Securities Act of
      1933,
      as amended (the “1933
      Act”).
      In
      connection with the Company’s obligations under the Registration Rights
      Agreement, on April 10, 2008, the Company filed a Registration Statement on
      Form
      SB-2 (File No. 333-________) (the “Registration
      Statement”)
      with
      the Securities and Exchange Commission (the “SEC”)
      relating to the resale of the Registrable Securities which names each of the
      present Purchasers as a selling stockholder thereunder.

     

    In
      connection with the foregoing, we advise you that a member of the SEC’s staff
      has advised us by telephone that the SEC has entered an order declaring the
      Registration Statement effective under the 1933 Act at [ENTER
      TIME OF EFFECTIVENESS]
      on
      [ENTER
      DATE OF EFFECTIVENESS]
      and we
      have no knowledge, after telephonic inquiry of a member of the SEC’s staff, that
      any stop order suspending its effectiveness has been issued or that any
      proceedings for that purpose are pending before, or threatened by, the SEC
      and
      accordingly, the Registrable Securities are available for resale under the
      1933
      Act pursuant to the Registration Statement.

     

    
      	Very
              truly yours,
	GUZOV
              OFSINK, LLC
	 
	 
	
              By:
                

            	 

    

     

    cc:
      [LIST
      NAMES OF PURCHASERS]

     

    
      
        
        

      

      
        52

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      H-1 TO THE 

    SECURITIES
      PURCHASE AGREEMENT

    ____________________________________________

     

    FORM
      OF OPINION OF COUNSEL

     

    
      
        
        

      

      
        53

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      H-2 TO THE 

    SECURITIES
      PURCHASE AGREEMENT

    ____________________________________________

     

    FORM
      OF OPINION OF PRC COUNSEL

     

    
      
        
        

      

      
        54

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      J TO THE 

    SECURITIES
      PURCHASE AGREEMENT

    ____________________________________________

     

    Use
      of Funds Schedule

     

    
      	
              Amount
                of Funds

            	 	
              Purposes

            
	
              $10
                million

            	 	
              Mergers
                and Acquisitions

            
	
              $6
                million

            	 	
              Hemo-Dialysis
                Centers

            
	
              $3
                million 

            	 	
              Transaction
                Costs

            
	
              $1
                million 

            	 	
              Additional
                Working Capital

            

    

    
      
        
        

      

      
        55

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      K TO THE

    SECURITIES
      PURCHASE AGREEMENT

    ____________________________________________

     

    Share
      Exchange Agreement

     

    
      
        
        

      

      
        56

        
          

        

      

      
        
        

      

    

    
       

      
        

        EXHIBIT
          A

        

        Securities
          Purchase Agreement

        
          
            
            

          

          
            57

            
              

            

          

          
            
            

          

        

        Schedule
          2.3 

        

        Subsidiaries
          of ATG

        

        None

         

        
          
            
            

          

          
            58

            
              

            

          

          
            
            

          

        

         

        Schedule
          3.3

        

        
          	
                   

                  Subsidiary
                    of ABM

                	
                   

                  ABM
                    Equity Interest

                
	 	 
	
                  Anhante
                    (Beijing) Medical Technology Co., Ltd.

                	
                  100%

                

        

         

        
          
            
            

          

          
            59

            
              

            

          

          
            
            

          

        

        Schedule
          B

        

        Capitalization
          Table

         

        
          
            
            

          

          
            60

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}]]